ACC ASIA 2026 | 2026년 춘계심혈관통합학술대회

4.17 Fri.

13:10-13:20

ENG Opening Ceremony

ACC

ENG Opening Ceremony

Apr. 17 (Fri.) 13:10-13:20, 300B

Chairpersons : Seok-Min Kang , Kwan Seung Lee , Roxana Mehran

08:40-10:10

Basic Research 1

KSC

Basic Research 1

유전자 편집 기술의 원리부터 심혈관질환 임상 적용까지

Apr. 17 (Fri.) 08:40-10:10, 102

Chairpersons : Jin-Ok Jeong , Pil-Ki Min

Panel : Young-Kook Kim , Jong-Ho Kim , Jihoon Nah , Han-Mo Yang , Kyung-Sun Heo

Learning Objective: This session introduces gene editing technology, from the basics to its clinical applications.

08:40-08:58	Principles of Gene Editing: From CRISPR-Cas9 to Next-Generation Editing Tools [Speaker] Kyoungmi Kim/Seoul National University, Korea
08:58-09:16	DNA Editing [Speaker] Hui Kwon Kim/Sungkyunkwan University, Korea
09:16-09:34	RNA Editing [Speaker] Younggwang Kim/Catholic Univ., Korea
09:34-09:52	Clinical Application of Gene Editing [Speaker] Jeong Hun Kim/Seoul National Univ., Korea
09:52-10:10	Discussion

Myocardial Infarction 1

KSC

Myocardial Infarction 1

심근경색증 진단하기 (증례를 중심으로)

Apr. 17 (Fri.) 08:40-10:10, 104

Chairpersons : Jin Yong Hwang , Young Joon Hong

Panel : Jong Pil Park , Chang-Hwan Yoon , Sang Yeub Lee , Hong-Seok Lim , Woong Gil Choi

Learning Objective: 1. In the era of AI, we will explore the utility and safety of AI-based electrocardiography in patients with myocardial infarction.
2. We will review how to interpret and utilize electrocardiography, troponin testing, and non-invasive tests in the diagnosis of myocardial infarction.
3. We will learn practical approaches to the differential diagnosis of myocardial infarction and related conditions.

08:40-08:55	AI 심전도 제대로 활용하기 [Speaker] Kyung Hoon Cho/Chonnam National Univ., Korea
08:55-09:10	고감도트로포닌검사 어떻게 해석하고 적용할 것인가? [Speaker] Ho Youn Won/Chung-Ang Univ., Korea
09:10-09:25	심근경색증의 비침습적 영상학적 검사 (Cardiac CT & MRI): 역할과 활용 [Speaker] Sanghoon Shin/Ewha Womans Univ., Korea
09:25-09:40	심근경색증인가요? 네, 맞습니다. [Speaker] Min Gyu Kang/Gyeongsang National Univ., Korea
09:40-09:55	심근경색증이 아닌가요? 네, 아닙니다. [Speaker] Hong Nyun Kim/Kyungpook National Univ., Korea
09:55-10:10	Discussion

ENG Hypertension

KSC

ENG Hypertension

New Era of Out-of-Office BP Monitoring: Guidelines, Evidence, and Technology

Apr. 17 (Fri.) 08:40-10:10, 105

Chairpersons : Jinho Shin , Kwang-il Kim

Panel : Sung Ha Park , Jeong-Hun Shin , Eun Mi Lee , Hae-Young Lee

Learning Objective: 1. To understand the technical principles of Cuffless BP monitoring and the current level of clinical validation.
2. To distinguish the expected clinical utility and limitations based on existing research findings.
3. To explain the role of cuffless blood pressure monitoring within current guidelines and outline future research directions.

08:40-08:55	Cuffless Blood Pressure Monitoring: Validation Status, Accuracy, and Reproducibility [Speaker] Min Gyu Kong/Soonchunhyang Univ., Korea
08:55-09:10	White Coat and Masked Hypertension: What Can Cuffless BP Monitoring Add? [Speaker] Hyung Joon Joo/Korea Univ., Korea
09:10-09:25	Nocturnal Hypertension and BP Dipping: Measuring the Unmeasurable [Speaker] Jieun Lee/Korea Univ., Korea
09:25-09:45	Cuffless BP Devices: Hype, Hope, and Hard Truths [Speaker] Daichi Shimbo/Columbia Univ., USA
09:45-10:10	Discussion

KSHF 1

KSHF

KSHF 1

Modern Drug Therapy for Heart Failure in Real Clinical Practice

Apr. 17 (Fri.) 08:40-10:10, 203

Chairpersons : Sukkeun Hong , Wook-Jin Chung

Panel : Min-Seok Kim , Chan Joo Lee , Hee Jeong Lee , Seongwoo Han

Learning Objective: 1. 최신 임상근거가 계속 확장되고 있는 새로운 심부전 약물을 증례를 통하여 Problem Solving하고 새로운 Evidence를 공부해 보는 세션입니다.
2. 주요 임상시험 근거를 바탕으로 각 치료 전략이 어떤 심부전 표현형과 환자군에서 가장 큰 임상적 이점을 가질 수 있는지를 해석할 수 있습니다.
3. 심부전 약물치료의 패러다임의 변화와 흐름을 이해할 수 있습니다.

08:40-08:55	[KOR] ARNI in HF mrEF and HFpEF: Expanding the Therapeutic Horizon [박출률 경도감소 및 보존 심부전에서 ARNI의 효과와 전망] [Speaker] Hyun-Jai Cho/Seoul National Univ., Korea
08:55-09:10	[KOR] Balanced Use of SGLT2 Inhibitor with Diuretics in HF [심부전 치료에서 SGLT2 inhibitor를 이뇨제와 적절히 사용하기] [Speaker] Kyeong-Hyeon Chun/Yonsei Univ., Korea
09:10-09:25	[ENG] Practical Approaches to GDMT Optimization in Challenging Clinical Settings [복잡한 임상상황에서의 GDMT최적화 전략] [Speaker] Aekarach Ariyachaipanich/Chulalongkorn University, Thailand
09:25-09:40	[KOR] GLP-1 Receptor Agonist in Heart Failure: A New Weapon Against a Major Enemy [심부전 환자의 비만 치료: 임상적용 실제] [Speaker] Jin Joo Park/Seoul National Univ., Korea
09:40-09:55	[KOR] Mavacamten in Obstructive HCM: Redefining Targeted Therapy [폐색성 비후성심근증에서 마바캄텐 치료의 다양한 경험] [Speaker] Jung-Woo Son/Yonsei Wonju Univ., Korea
09:55-10:10	Discussion

Cardiometabolic Syndrome 1

KSC

Cardiometabolic Syndrome 1

Deconstructing the "Fatty" CKM: Adiposity and Inflammation

Apr. 17 (Fri.) 08:40-10:10, 300B

Chairpersons : Seung Hwan Han , Byung Jin Kim

Panel : Jae Hyoung Park , Jae Bin Seo , Jong Shin Woo , Dae Young Cheon

Learning Objective: 1. To understand the local pathophysiology of ectopic fat: the mechanisms by which PVAT, EAT, and hepatic fat induce atherosclerosis, heart failure, fatty liver, and insulin resistance through inflammatory signaling and mechanical compression.
2. To identify organ-specific mechanisms of injury: to learn whether fat-induced damage, depending on anatomical location, is driven by inflammatory (chemical) signals or mechanical compression.
3. To understand the redefinition of ectopic fat and CKM pathophysiology: recognizing that, beyond BMI, fat accumulation in the heart, vasculature, and liver may be a key driver of CKM diseases.

08:40-08:55	Obesity-Related Hypertension: Cardiometabolic Insights [Speaker] Sang-Ho Jo/Hallym Univ., Korea
08:55-09:10	Central Adiposity or Hypertension: Which Drives HFpEF? [Speaker] Jeong Cheon Choe/Pusan National Univ., Korea
09:10-09:25	Epicardial Adipose Tissue (EAT): Mechanical Constraint or Paracrine Toxicity? [Speaker] Mi Hye Seo/Soonchunhyang Univ., Korea
09:25-09:40	Perivascular Adipose Tissue (PVAT): The "Outside-In" Signaling in Atherosclerosis [Speaker] Hun-Jun Park/Catholic Univ., Korea
09:40-09:55	Metabolic Engine of CKM: Insulin Resistance and Liver Fat [Speaker] Se Eun Park/Sungkyunkwan Univ., Korea
09:55-10:10	Discussion

Interesting ECG

KHRS

Interesting ECG

Apr. 17 (Fri.) 08:40-10:10, 300C

Chairpersons : June Huh , Young Keun On

Panel : Yeji Kim , Yoon Jung Park , Dong Geum Shin , So Young Yang , Joo Hee Jeong

Learning Objective: 1. 서맥·빈맥·심박동기·소아 ECG를 포함한 다양한 부정맥 심전도를 체계적으로 해석할 수 있는 능력을 습득한다.
2. Narrow QRS 및 Wide QRS 빈맥 감별 시 핵심 포인트와 흔한 오류를 케이스 기반으로 이해한다.
3. 웨어러블 및 AI 기반 심전도 판독의 임상적 활용 범위와 진단적 한계를 파악하여 실제 진료에 적용한다.

08:40-08:55	What are the key ECG findings in bradycardia and pacemaker rhythms? [Speaker] Moon-Hyun Kim/Ewha Womans Univ., Korea
08:55-09:10	Practical differentiation of narrow QRS tachycardia: What matters most? [Speaker] Young Shin Lee/Kyung Hee Univ., Korea
09:10-09:25	Wide QRS tachycardia: Is it VT or not? [Speaker] Min-Su Jung/Keimyung Univ., Korea
09:25-09:40	What are the key ECG features in pediatric and congenital heart disease? [Speaker] Nuri Cha/Yonsei Univ., Korea
09:40-09:55	ECG from Wearables & AI-Driven ECG Interpretation: What should clinicians know? [Speaker] Yongsoo Baek/Inha Univ., Korea
09:55-10:10	Discussion

10:30-12:00

ENG Basic Research 2

KSC

ENG Basic Research 2

From Bedside to Bench: Patient-Derived Samples in Cardiovascular Research

Apr. 17 (Fri.) 10:30-12:00, 102

Chairpersons : Jin Han , Hun-Jun Park

Panel : Hae Young Yang , Chang-Myung Oh , Sung Woo Cho , Hyung Joon Joo

Learning Objective: This session introduces cardiovascular translational research that can be conducted using patient-derived samples (e.g., blood, tissue).

10:30-10:48	Targeting Fibrosis in Cardiovascular-metabolic Diseases [Speaker] Ippei Shimizu/National Cerebral and Cardiovascular Center, Japan
10:48-11:06	High-definition Spatial Mapping of the Peri-fibrotic Remodeling Front in End-stage Ischemic Cardiomyopathy [Speaker] Kwon Joong Na/Seoul National Univ., Korea
11:06-11:24	Disease Modeling by Using Patient Specific iPSC-dervied Cell [Speaker] Derek J. Hausenloy/Duke-National University of Singapore Medical School, Singapore
11:24-11:42	Patient-Derived Aortic Valve Omics for Mechanistic Studies in Aortic Stenosis [Speaker] Sahmin Lee/Ulsan Univ., Korea
11:42-12:00	Discussion

Insurance Issues

KSC

Insurance Issues

심장분야 의료기기 및 혁신AI기술의 국산화와 과제

Apr. 17 (Fri.) 10:30-12:00, 104

Chairpersons : Bon-Kwon Koo , Jon Suh

Panel : Seongcheol Kim , Joonyoung Kim , Il-Young Oh , Jung-min Yoo , Seung-Yul Lee

10:30-10:45	심장 진료의 새로운 전환: 진단 보조 AI의 임상 적용과 급여의 현실 [Speaker] Yongsoo Baek/Inha Univ., Korea
10:45-11:00	디지털 헬스케어의 시장 진입과규제 (혁신의료기술 업계의 고충) [Speaker] Eun Bo Shim/AI Medic, Korea
11:00-11:15	Discussion
11:15-11:30	국산의료기기 개발 경험과 과제 [Speaker] Min Ku Chon/Punsan National Univ., Korea
11:30-11:45	국산 심혈관 치료재료 개발 현실과 애로사항 (스텐트, 카테터 등 의료기기 제조 기술 중심으로) [Speaker] Woojin Kim/KITECH, Korea
11:45-12:00	Discussion

Pulmonary Hypertension

KSC

Pulmonary Hypertension

Current Therapeutic Approaches in Pulmonary Hypertension

Apr. 17 (Fri.) 10:30-12:00, 105

Chairpersons : Wook-Jin Chung , Kye Hun Kim

Panel : Hyungdon Kook , Jin Oh Na , Won Jae Lee , Se Yong Jung

Learning Objective: 1. To understand the classification of pulmonary hypertension.
2. To understand the characteristics, diagnosis, and treatment of each group of pulmonary hypertension.

10:30-10:45	Pulmonary Arterial Hypertension (PAH) [Speaker] Sang-Eun Lee/Ewha Womans Univ., Korea
10:45-11:00	Pulmonary Hypertension in Left Heart Disease [Speaker] Jin Oh Choi/Sungkyunkwan Univ., Korea
11:00-11:15	Pulmonary Hypertension in Chronic Lung Disease [Speaker] Hang Je Jang/Inje Univ., Korea
11:15-11:30	Chronic Pulmonary Thromboembolism Pulmonary Hypertension (CTEPH) [Speaker] Chul-Min Ahn/Yonsei Univ., Korea
11:30-11:45	WHO Group 5 Pulmonary Hypertension [Speaker] Seung Min Baek/Seoul National Univ., Korea
11:45-12:00	Discussion

Cardiac Pathology

KSC

Cardiac Pathology

Tissue Based Approach: Integrated Patho-cardiology Strategies for Immune Checkpoint Inhibitor Myocarditis and Radiation Induced Heart Disease

Apr. 17 (Fri.) 10:30-12:00, 203

Chairpersons : Chang-Ha Lee , Woo-Baek Chung

Panel : Hyung Seop Kim , Jeong Wook Seo , Hyun Ju Yoon , Jung Sun Cho , Hui-Jeong Hwang

Learning Objective: 1. To intuitively understand the pathological mechanisms of myocarditis occurring after immune checkpoint inhibitor therapy through histopathology and immunohistochemistry (IHC) images.
2. To Learn a strategic approach to endomyocardial biopsy in clinically suspected ICI myocarditis through real-world clinical cases.
3. To understand the evolving patterns and clinical spectrum of radiation-induced heart disease (RIHD) in the context of advances in radiation dose and treatment techniques.
4. To intuitively understand histological injury and histomorphological changes following cardiac radiation therapy through actual cardiac tissue images, and to correlate these findings with clinically observed cardiovascular complications.

10:30-10:50	Pathological Features of ICI Myocarditis [Speaker] Jung Sun Kim/Sungkyunkwan Univ., Korea
10:50-11:10	Biopsy-guided Therapy for ICI Myocarditis (Clinical Impact and Outcomes) [Speaker] Mi-Hyang Jung/Catholic Univ., Korea
11:10-11:30	Evolving Clinical Landscape of Radiation-Induced Heart Disease in Modern Thoracic Radiotherapy [Speaker] Hong-In Yoon/Yonsei Univ., Korea
11:30-11:50	Pathological Insights of Radiation Induced Heart Disease [Speaker] Eun Na Kim/Seoul National Univ., Korea
11:50-12:00	Discussion

Cardiometabolic Syndrome 2

KSC

Cardiometabolic Syndrome 2

RNA Revolution: Silencing the Drivers of CKM Syndrome

Apr. 17 (Fri.) 10:30-12:00, 300B

Chairpersons : Sung Kee Ryu , Weon Kim

Panel : Sung Eun Kim , Jang-Young Kim , Jun Namkung , Jeong Geun Moon , Soon Jun Hong

Learning Objective: 1. To understand the mechanisms of action and clinical significance of RNA-based therapies, which are emerging as novel treatment strategies.
2. To understand the molecular biological mechanisms by which RNA therapeutics, such as siRNA and ASOs, regulate gene expression, and how they intervene in the core pathophysiology of clinical conditions comprising the CKM syndrome, including dyslipidemia, hypertension, and heart failure.
3. To compare and evaluate the clinical evidence and therapeutic strategies of RNA therapeutics in dyslipidemia, hypertension, and heart failure.
4. To comprehensively recognize the limitations, safety considerations, and practical aspects of clinical application of RNA-based therapies.

10:30-10:50	Dawn of Gene Silencing: Mechanism and Potential of RNA Therapeutics in CKM Syndrome [Speaker] Jin Wi/Gachon Univ., Korea
10:50-11:05	Navigating the Maze: Challenges and Breakthroughs of RNA Therapies in HF [Speaker] Kyung-Hee Kim/Incheon Sejong Hospital, Korea
11:05-11:25	Shifting the Paradigm in Lipid Management with RNA Therapeutics [Speaker] Nam Hoon Kim/Korea Univ., Korea
11:25-11:40	Beyond Conventional Pills: RNA Therapeutics as the Next Frontier in Hypertension Control [Speaker] Hyo Suk Ahn/Catholic Univ., Korea
11:40-12:00	Discussion

KHRS1-AF

KHRS

KHRS1-AF

Atrial Fibrillation: State-of-the-Art 2026

Apr. 17 (Fri.) 10:30-12:00, 300C

Chairpersons : Choong Hwan Kwak , Myung-Yong Lee

Panel : Yun Gi Kim , Jang Won Sohn , Minsoo Ahn , Sung-Won Jang , Youngjin Cho

Learning Objective: AF ablation 후 장기 항응고 치료 지속의 필요성에 대한 최신 근거와 변화된 접근을 이해한다.
Device-detected AF 환자에서 항응고 치료의 필요성과 시기를 결정하는 최신 임상 근거를 이해하고 적용할 수 있다.
PFA를 이용한 AF 절제술에서 PVI 이외 영역에 대한 시술 전략의 근거와 향후 방향을 논의한다.
HFpEF와 AF가 동반된 환자에서 최적의 치료 전략을 이해하고, 약물 치료와 조기 리듬 조절의 역할을 비교해 본다.
좌심방이 폐색술의 현재 역할과 임상 근거를 이해하고, 향후 발전 방향을 파악할 수 있도록 한다.

10:30-10:45	Stroke Prevention After AF Ablation: How Are Long-Term Anticoagulation Strategies Changing? [Speaker] Daehoon Kim/Yonsei Univ., Korea
10:45-11:00	When and in Whom Should Anticoagulation Be Initiated for Device-Detected Atrial Fibrillation? [Speaker] Namsik Yoon/Chonnam National Univ., Korea
11:00-11:15	How Can Pulsed Field Ablation Redefine AF Ablation Strategies Beyond Pulmonary Vein Isolation? [Speaker] Hyoung-Seob Park/Keimyung Univ., Korea
11:15-11:30	How Should HFpEF With AF Be Optimally Managed: Medical Therapy or Early Rhythm Control? [Speaker] Jiwon Seo/Yonsei Univ., Korea
11:30-11:45	What Is the Role of Left Atrial Appendage Closure in 2026: Current Evidence and Future Directions? [Speaker] Soonil Kwon/Cha Univ., Korea
11:45-12:00	Discussion

12:20-13:00

Scientific Session [Chong Kun Dang]

KSC

Scientific Session [Chong Kun Dang]

Evolution of Cardiovascular Care: Redefining Strategies for Hypertension and Heart Failure

Apr. 17 (Fri.) 12:20-13:00, 102

Chairpersons : Jung Hyun Choi , Hyoung-Seob Park

12:20-12:40	Paradigm Shift in HTN Treatment: Role of Low-dose Dual Combination [Speaker] Jung-Kyu Han/Seoul National Univ., Korea
12:40-13:00	Optimizing Heart Failure Treatment: Revisiting Carvedilol and Expanding with Vericiguat [Speaker] Bong Joon Kim/Kosin Univ., Korea

Scientific Session [Hanmi]

KSC

Scientific Session [Hanmi]

Early Combination Therapy: A Paradigm Shift in CVD Treatment

Apr. 17 (Fri.) 12:20-13:00, 105

Chairpersons : Kwang-il Kim , Byeong-Keuk Kim

12:20-12:40	Ultra Low-Dose Triple FDC in Hypertension: A New Initial Treatment Paradigm and the Patients Who Benefit [Speaker] Dae-Hee Kim/Ulsan Univ., Korea
12:40-13:00	Beyond The Statin; Start Early, Switch Now [Speaker] Kwon Oh Sung/Catholic Univ., Korea

Scientific Session [Novartis]

KSC

Scientific Session [Novartis]

Beyond LDL-C Reduction: Consistent Control

Apr. 17 (Fri.) 12:20-13:00, 203

Chairpersons : In-Ho Chae , Sang-Hyun Kim

12:20-12:35	Bridging the Gap in LDL-C Control with the Long-Sustained Efficacy of Inclisiran [Speaker] Ki Hong Choi/Sungkyunkwan Univ., Korea
12:35-12:50	Redefining LDL-C Control through Minimizing LDL-C Variability with Inclisiran [Speaker] Jung-Joon Cha/Korea Univ., Korea
12:50-13:00	Discussion

Scientific Session [Amgen]

KSC

Scientific Session [Amgen]

The Evolving Role of Evolocumab in ACS: Optimizing Lipid Management and Cardiovascular Outcomes

Apr. 17 (Fri.) 12:20-13:00, 300B

Chairpersons : Bon-Kwon Koo , Jin-Ok Jeong

Panel : Hyoung-Won Cho , Ick Joon Choi

12:20-12:35	Bridging the Gap in Lipid Management: Between Guideline and Real-World Practice [Speaker] Kyung Hoon Cho/Chonnam National Univ., Korea
12:35-12:50	Evolocumab in ACS: Early Initiation for Long-Term Cardiovascular Benefit [Speaker] Yong Cheol Kim/Yonsei Univ., Korea
12:50-13:00	Discussion

Scientific Session [Boryung]

KSC

Scientific Session [Boryung]

Comprehensive Cardiovascular Disease Management

Apr. 17 (Fri.) 12:20-13:00, 300C

Chairpersons : Seok-Min Kang , Byung Su Yoo

12:20-12:40	Optimal Approach for HMOD Management with Fimasartan Combination Theraphy [Speaker] Sung-Hee Shin/Inha Univ., Korea
12:40-13:00	New Treatment Option for Patients with Hypertension and Dyslipidemia [Speaker] Sung Pyo Hong/Daegu Catholic Univ., Korea

Scientific Session [Samjin]

KSC

Scientific Session [Samjin]

Contemporary Approaches to Managing Pediatric Pulmonary Arterial Hypertension

Apr. 17 (Fri.) 12:20-13:00, 205

Chairperson : I Seok Kang

12:20-12:40	From Guidelines to Patient Care: Practical Approaches to Managing Eisenmenger Syndrome [Speaker] Hyun Chung/Bucheon Sejong Hospital, Korea
12:40-13:00	Long-term Management of Pediatric Pulmonary Arterial Hypertension [Speaker] Se Yong Jung/Yonsei Univ., Korea

Scientific Session [Organon]

KSC

Scientific Session [Organon]

Redefining Lipid Control with Atorvastatin Plus Ezetimibe for Early and Optimal LDL-C Reduction

Apr. 17 (Fri.) 12:20-13:00, 300A

Chairpersons : Kook-Jin Chun , Chang-Wook Nam

12:20-12:40	Start Early: Upfront Lipid-Lowering Combination Therapy for Early Achievement of LDL-C Treatment Goals [Speaker] Jin Wi/Gachon Univ., Korea
12:40-13:00	Start Strong: Elevating LDL-C Management in ASCVD with High-Dose Atorvastatin Plus Ezetimibe [Speaker] Suk Min Seo/Catholic Univ., Korea

13:20-14:00

ENG Suh, Soon Kyu Memorial Lecture

KSC

ENG Suh, Soon Kyu Memorial Lecture

Apr. 17 (Fri.) 13:20-14:00, 300B

Chairpersons : Youngkeun Ahn , Seok-Min Kang

13:20-14:00	Cardiovascular Medicine in the Age of Intelligent Systems: From Data to Trust [Speaker] Harlan M. Krumholz/Yale School of Medicine, USA

14:15-15:45

Adult Congenital Heart Disease 1

KSC

Adult Congenital Heart Disease 1

Pulmonary Arterial Hypertension in Adult Congenital Heart Disease: From Pathophysiology to Management

Apr. 17 (Fri.) 14:15-15:45, 102

Chairpersons : June Huh , Lucy Youngmin Eun

Panel : Geena Kim , Jae-Hyeong Park , Hwa Jin Cho , Kwang Ho Choi , Ran Heo

Learning Objective: 1. To understand pulmonary arterial hypertension in adult congenital heart disease (ACHD).
2. To be familiar with the latest pharmacologic and surgical treatment options applicable to patients with pulmonary arterial hypertension.
3. To understand borderline pulmonary arterial hypertension and discuss its management.

14:15-14:30	Pathophysiology of PAH(Pulmonary Arterial Hypertension) in ACHD [Speaker] Se Yong Jung/Yonsei Univ., Korea
14:30-14:45	New Emerging Therapeutic Agents for PAH in ACHD [Speaker] Hyun Ju Yoon/Chonnam National Univ., Korea
14:45-15:00	Borderline PAH in ACHD, Definition and Management [Speaker] Jae Suk Baek/Ulsan Univ., Korea
15:00-15:15	Imaging of PAH in ACHD [Speaker] Sang Hyun Lee/Pusan National Univ., Korea
15:15-15:30	Surgical Management of PAH in ACHD [Speaker] Eun Seok Choi/Ulsan Univ., Korea
15:30-15:45	Discussion

Myocardial Infarction 2

KSC

Myocardial Infarction 2

심근경색증 치료하기 (최신연구를 중심으로)

Apr. 17 (Fri.) 14:15-15:45, 104

Chairpersons : Myung Ho Jeong , Weon Kim

Panel : Woohyeun Kim , Ung Kim , Sungjoon Park , Joo-Yong Hahn , Jung Ho Heo

Learning Objective: 1. To review recent studies on antiplatelet agents and beta-blockers and understand their clinical implications.
2. To review the recently updated dyslipidemia guidelines and explore lipid-lowering strategies using new therapeutic agents.
3. To summarize recent studies in the field of interventional cardiology and discuss how to apply them in clinical practice.

14:15-14:30	복잡한 항혈소판제제 최신연구 한번에 정리하기 [Speaker] Song-Yi Kim/Jeju National Univ., Korea
14:30-14:45	강화된 지질치료전략 어떻게 적용할 것인가? [Speaker] Seung-Jun Lee/Yonsei Univ., Korea
14:45-15:00	베타차단제 누구에게 쓰고 언제 중단할 것인가? [Speaker] Jong Il Park/Yeungnam Univ., Korea
15:00-15:15	다혈관질환자의 관상동맥 중재시술 어떻게 할 것인가? [Speaker] Sang Ho Park/Soonchunhyang Univ., Korea
15:15-15:30	심인성쇼크 환자의 기계적 순환장치: 누구에게, 어떤 것을, 언제 시행할 것인가? [Speaker] Soo Yong Lee/Pusan National Univ., Korea
15:30-15:45	Discussion

Women Heart Disease

KSC

Women Heart Disease

Sex-Based Differences in Emerging Cardiovascular Risk Factors

Apr. 17 (Fri.) 14:15-15:45, 105

Chairpersons : Kee Sik Kim , Mi-Seung Shin

Panel : Soo-Jin Kim , Yong Hyun Park , In-Jeong Cho , Kyung-Kuk Hwang

Learning Objective: 1. To understand sex differences in cardiovascular risk factors and to explain how, beyond traditional risk factors, emerging cardiometabolic, mental health, and social factors influence the development and prognosis of cardiovascular disease in women.
2. To recognize cardiovascular risks across the female life course and in special clinical situations-such as pregnancy and childbirth, cancer therapy, and mental health conditions-and to understand the need for sex-specific risk assessment and longitudinal management strategies.

14:15-14:30	Cardiometablic Health [Speaker] Sang-Ho Jo/Hallym Univ., Korea
14:30-14:45	Updates in Cardio-obstetrics [Speaker] Kyunghee Lim/Dong-A Univ., Korea
14:45-15:00	Social Determinants of Health in Cardiovascular Disease [Speaker] Hyue Mee Kim/Chung-Ang Univ., Korea
15:00-15:15	Mental Health and Cardiovascular Health [Speaker] Eun Joo Cho/Catholic Univ., Korea
15:15-15:30	Cardio-oncololgy in Women [Speaker] Jeong Yeon Jin/Eulji Univ., Korea
15:30-15:45	Discussion

Cardiovascular Imaging

KSC

Cardiovascular Imaging

From Cancer Therapy to Cardiac Injury: Clinical and Imaging Perspectives on Cardiotoxicity, Including ICI-Related Myocarditis

Apr. 17 (Fri.) 14:15-15:45, 203

Chairpersons : Jae K. Oh , Dae-Hee Kim

Panel : Jeong Geun Moon , Moon Seung Soh , Jihee Son , Jin Chul Paeng

Learning Objective: 1. With the rapid advances in cancer therapy, novel anticancer agents are emerging at an unprecedented pace. This session aims to understand their cardiovascular effects and identify high-risk patients.
2. To understand the various clinical scenarios of myocarditis associated with immune checkpoint inhibitors and the corresponding diagnostic algorithms.
3. To understand the roles of cardiac MRI and nuclear imaging, in addition to echocardiography, in the assessment of cardiotoxicity and the diagnosis of ICI-related myocarditis, and to appropriately select and interpret these imaging modalities.

14:15-14:35	A Review of Contemporary Cancer Therapies Associated with Increased Risk of Cardiotoxicity, Including Immune Checkpoint Inhibitors [Speaker] Sung Ae Koh/Yeungnam Univ., Korea
14:35-14:55	Clinical Scenarios Associated with Increased Risk of Immune Checkpoint Inhibitor-Related Myocarditis in Patients with Cancer: Diagnosis and Management Pathways [Speaker] So Young Lee/Catholic Univ., Korea
14:55-15:15	Current and Emerging Roles of Cardiac MRI in the Evaluation and Diagnosis of Cardiotoxicity, with a Focus on Immune Checkpoint Inhibitor-Related Myocarditis [Speaker] Yoo Jin Hong/Yonsei Univ., Korea
15:15-15:35	Nuclear Imaging in the Assessment and Diagnosis of Cardiotoxicity [Speaker] Sang-Geon Cho/Chonnam National Univ., Korea
15:35-15:45	Discussion

KSIC 1

KSIC

KSIC 1

Optimizing Antithrombotic Therapy after PCI in Patients Requiring Oral Anticoagulation

Apr. 17 (Fri.) 14:15-15:45, 300B

Chairpersons : Doo Il Kim , Bum-Kee Hong

Panel : Min Chul Kim , Kyung Woo Park , Eun-Seok Shin , Young-Hoon Jeong , Yun Kyeong Cho

Learning Objective: 1. 항응고 치료가 필요한 환자에서 PCI 이후 항혈전 치료 전략을 최신 근거를 바탕으로 체계적으로 살펴봅니다.
2. 시술 시기, 출혈 및 허혈 위험, 시술 복잡도에 따른 약제 선택과 치료 기간 최적화에 대한 실제 임상 적용 방안을 함께 논의해 봅니다.

14:15-14:30	Revisiting Triple Therapy after PCI: Who Needs It, When, and for How Long? [Speaker] Hyun Sung Joh/SMG-SNU Boramae Medical Center, Korea
14:30-14:45	Optimizing Dual Therapy: Which DOAC and Which P2Y12 Inhibitor? [Speaker] Jung-Joon Cha/Korea Univ., Korea
14:45-15:00	Personalized Antithrombotic Therapy Based on Bleeding and Thrombotic Risk [Speaker] Yong-Joon Lee/Yonsei Univ., Korea
15:00-15:15	Does Procedural Complexity Matter in Antithrombotic Decision-Making? [Speaker] Jung-Won Suh/Seoul National Univ., Korea
15:15-15:30	When Is Oral Anticoagulant Monotherapy Sufficient after PCI? [Speaker] Ki Hong Choi/Sungkyunkwan Univ., Korea
15:30-15:45	Discussion

KHRS2-SCD

KHRS

KHRS2-SCD

Sudden cardiac death

Apr. 17 (Fri.) 14:15-15:45, 300C

Chairpersons : Yongkeun Cho , Nam-Ho Kim

Panel : Hye Bin Gwag , Jinsun Park , Ja Kyoung Yoon , Joong Min Lee , Tae Wan Chung

Learning Objective: 1. 돌연 심장사의 주요 비침습적 위험인자와 영상학적 마커, 유전적인 관련성을 이해한다.
2. 다양한 심근병증에서 돌연심장사 위험인자를 파악한다.
3. 인공지능 모델이 돌연심장사 예측에 어떻게 적용되는지 이해한다.
4. 운동선수에서 발생하는 돌연심장사의 역학적 특징과 위험인자 관리, 원인에 대해 이해한다.

14:15-14:30	Non-invasive and Imaging Markers of Sudden cardiac death: what are they? [Speaker] Chan Hee Lee/Yeungnam Univ., Korea
14:30-14:45	Understand the genetics related to sudden cardiac death [Speaker] Hwa Jung Kim/Catholic Univ., Korea
14:45-15:00	What are the key risk factors for sudden cardiac death in cardiomyopathies and the strategeis for its prevention? [Speaker] Hanjin Park/Yonsei Univ., Korea
15:00-15:15	Exploring Multimodal AI approaches for Sudden cardiac death risk stratification beyond ejection freaction. [Speaker] Joon-Myoung Kwon/Incheon Sejong Hospital, Korea
15:15-15:30	Sudden cardiac deaht in Athletes: What are the epidemiology, etioloty, and risk factors? [Speaker] Moo Nyun Jin/Incheon Sejong Hospital, Korea
15:30-15:45	Discussion

Rare Genetic CVD 1

KSC

Rare Genetic CVD 1

How to Diagnose Rare Genetic CVD?

Apr. 17 (Fri.) 14:15-15:45, 힐튼호텔 파인룸(1F)

Chairpersons : Myeong-Chan Cho , Sang-Hak Lee

Panel : Jun-Bean Park , Hee Tae Yu , Joon Chul Jung , Jong-Il Choi

Learning Objective: 1. To review rare inherited cardiac diseases.
2. To review diagnostic approaches for representative rare cardiac conditions.

14:15-14:35	Familial Hypercholesterolemia [Speaker] Chan Joo Lee/Yonsei Univ., Korea
14:35-14:55	Brugada/Long QT Syndrome & CPVT [Speaker] Joo Hee Jeong/Korea Univ., Korea
14:55-15:15	Aortopathy, From Aneurysm to Dissection? [Speaker] Taek Kyu Park/Sungkyunkwan Univ., Korea
15:15-15:35	Hypertrophic Cardiomyopathy & Its Mimicker e.g. Amyloidosis [Speaker] Chi Young Shim/Yonsei Univ., Korea
15:35-15:45	Discussion

16:05-17:35

Adult Congenital Heart Disease 2

KSC

Adult Congenital Heart Disease 2

Small Shunt Is Really Simple?

Apr. 17 (Fri.) 16:05-17:35, 102

Chairpersons : Chang-Ha Lee , Jun-Bean Park

Panel : Woong Chol Kang , Chang Sin Kim , JinYoung Song , Hyo Suk Ahn

Learning Objective: 1. To understand the natural history of small shunts in adults.
2. To review treatment options for various small shunts in adults.
3. To understand potential complications associated with small shunts in adults.

16:05-16:20	Small ASD(Atrial Septal Defect) Is Really Benign in Adults? [Speaker] I Seok Kang/Sungkyunkwan Univ., Korea
16:20-16:35	Treatment of Small PDA in Adults [Speaker] Hoon Ko/Pusan National Univ., Korea
16:35-16:50	Clinical Impact and Management of Small VSD(Ventricular Septal Defect) in Adults [Speaker] Han Ki Park/Yonsei Univ., Korea
16:50-17:05	Small Shunt and Arrhythmias [Speaker] Ji Eun Ban/Bucheon Sejong Hospital, Korea
17:05-17:20	Small Shunt and Pulmonary Hypertension [Speaker] Yi Sik Kim/Jeonbuk National Univ., Korea
17:20-17:35	Discussion

ENG Epidemiology

KSC

ENG Epidemiology

From Evidence to Action: Global Implementation Strategies for CVD Prevention

Apr. 17 (Fri.) 16:05-17:35, 104

Chairpersons : Daichi Shimbo , Hyeon Chang Kim

Panel : Eunji Kim , Min-Jeong Shin , Jeong-Hun Shin , Se Young Jae

Learning Objective: 1. To understand real-world implementation strategies for improving blood pressure control, based on the U.S. experience.
2. To identify key barriers and enabling factors in implementing lifestyle modification strategies for CVD prevention.
3. To explore regional models and outcomes of community-based cardiovascular disease prevention programs in Korea.
4. To discuss how national surveillance data can be translated into effective public health policies and prevention strategies.

16:05-16:25	Implementation Strategies to Improve Blood Pressure Control: U.S. Perspective [Speaker] Daichi Shimbo/Columbia Univ., USA
16:25-16:40	Community-Based CVD Prevention Program: From Population Health to Practice [Speaker] Kunhee Park/Pyeongchang County Public Health Center, Korea
16:40-16:55	Lifestyle Modification for CVD Prevention: Barriers and Strategies for Implementation [Speaker] Jung Eun Lee/Seoul National University, Korea
16:55-17:10	From Surveillance to Impact: Applying Population Data to National CVD Strategies [Speaker] Hokyou Lee/Yonsei Univ., Korea
17:10-17:35	Discussion

KSE 1

KSE

KSE 1

Echocardiographic Hemodynamics: From Physiology to Clinical Decision-Making

Apr. 17 (Fri.) 16:05-17:35, 105

Chairperson : Seung Woo Park

Panel : Minjeong Kim , Sun Hwa Lee , Hyemoon Chung , Kang-Un Choi

16:05-16:25	Forward Flow & Cardiac Power [Speaker] Sang Hyun Lee/Pusan National Univ., Korea
16:25-16:45	Volume Optimizatiom with Diastology and POCUS [Speaker] Hyukjin Park/Chonnam National Univ., Korea
16:45-17:05	Hemodynamic Reserve Through Exercise Echocardiography [Speaker] Seo Yeon Gwak/Korea Univ., Korea
17:05-17:25	Ventricular-Arterial Coupling Integrating Flow and Afterload [Speaker] Jung-Woo Son/Yonsei Wonju Univ., Korea
17:25-17:35	Discussion

ENG Cardio-Oncology

KSC

ENG Cardio-Oncology

Update on Cardio-Oncology 2026

Apr. 17 (Fri.) 16:05-17:35, 203

Chairpersons : Kee Sik Kim , Woo-Baek Chung

Panel : Do Young Kim , Nuri Lee , So Young Lee , Yun Gyoo Lee , Jung Sun Cho

Learning Objective: 1. To understand how CV biomarkers can be used for risk stratification, early detection, and monitoring of cardiotoxicity in cancer patients
2. To recognize the role of rare pathogenic genetic variants in cardiomyopathy-related genes as contributors to individual susceptibility to CTRCD
3. To appreciate the impact of lifestyle modification on CV health and long-term outcomes in cancer patients and survivors

16:05-16:25	The Role of Biomarkers in Cardio-Oncology [Speaker] Bonnie Ky/University of Pennsylvania School of Medicine, USA
16:25-16:45	Rare Deleterious Variants in Cardiomyopathy Genes Contribute to CTRCD Pathogenesis [Speaker] Hiroshi Akazawa/Kanazawa Medical University, Japan
16:45-17:05	Nationwide Population-Based Cardio-Oncology Research in Korea [Speaker] Jong-Chan Youn/Catholic Univ., Korea
17:05-17:35	Discussion

Healthcare Policy

KSC

Healthcare Policy

필수의료 위기 극복을 위한 심뇌혈관질환 관리 체계의 대전환

Apr. 17 (Fri.) 16:05-17:35, 300B

Chairpersons : Dong Heon Yang , Wook-Jin Chung

Panel : Jin-Bae Kim , Jon Suh , Sung-Hee Shin , Joong-kyu Lee , Chan Joo Lee

Learning Objective: 1. 중앙-권역-지역 심뇌혈관질환센터의 역할 분담과, 새롭게 도입되는 인적 네트워크 기반의 진료 협력 체계를 이해합니다.
2. 중증·응급 심혈관질환에 대한 보상 강화, 이송 체계 개편 등 구체적인 지원 방안과 기대 효과를 파악합니다.
3. 지속 가능한 심뇌혈관 안전망 구축을 위해 학계와 정부가 해결해야 할 법적·제도적 선결 과제를 논의합니다.

16:05-16:25	중앙-권역-지역 심뇌혈관질환 전달체계 구축과 중앙센터의 컨트롤 타워 역할 [Speaker] Hae-Young Lee/Seoul National Univ., Korea
16:25-16:45	중증응급 이송·전원 체계 개편과 심혈관질환 지원 정책의 방향 [Speaker] Jung-min Yoo/Ministry of Health and Welfare, Korea
16:45-17:05	심뇌혈관질환관리법 개정 이슈와 심장질환 국가책임제의 법적 과제 [Speaker] Wook-Jin Chung/Gachon Univ., Korea
17:05-17:35	Discussion

KSoLA 1

KSoLA

KSoLA 1

New direction of Korean Guideline for?Lipid Management

Apr. 17 (Fri.) 16:05-17:35, 300C

Chairpersons : Sang-Hyun Kim , Woo je Lee

Panel : Byung Sik Kim , Hyun-Jin Kim , Youngwoo Jang , Soon Jun Hong

Learning Objective: 1. 한국인 1차 예방에서 최근 근거와 국내 자료를 바탕으로 LDL-C 목표 수치를 재정의하고 위험도에 따라 차등 적용하는 원칙을 이해한다.
2. HDL-C 수치뿐 아니라 입자 특성, 동반 위험인자, 지질지표를 통합하여 동맥경화성 심혈관질환 발생 위험을 보다 정밀하게 예측하는 접근법을 습득한다.
3. 고위험 환자에서 스타틴 단독요법의 한계를 이해하고, 초기 단계부터 에제티미브·PCSK9 억제제 등 비스타틴 제제를 병용하는 전략의 적응증과 기대 효과를 정리한다.

16:05-16:25	LDL-C targets for primary prevention in Korean [Speaker] Jong Han Choi/Konkuk Univ., Korea
16:25-16:45	Risk prediction with HDL-C [Speaker] Yun Kyung Cho/Ulsan Univ., Korea
16:45-17:05	Early combination of non-statin therapy in high-risk patients [Speaker] Jaehoon Chung/Dongguk Univ., Korea
17:05-17:35	Discussion

Rare Genetic CVD 2

KSC

Rare Genetic CVD 2

Up-to-date Treatment for Rare Genetic CVD

Apr. 17 (Fri.) 16:05-17:35, 힐튼호텔 파인룸(1F)

Chairpersons : Seok-Min Kang , Jin-Ok Jeong

Panel : Hack-Lyoung Kim , Jaewon Oh , Sang Eun Lee , Jung Hyun Choi

Learning Objective: To review the latest treatment strategies for representative rare cardiac diseases.

16:05-16:25	Familial Hypercholesterolemia [Speaker] Jae Hyoung Park/Korea Univ., Korea
16:25-16:45	Pulmonary Hypertension [Speaker] Ran Heo/Hanyang Univ., Korea
16:45-17:05	Hypertrophic Cardiomyopathy [Speaker] Hyung-Kwan Kim/Seoul National Univ., Korea
17:05-17:25	Transthyretin Amyloidosis [Speaker] Seung Pyo Lee/Seoul National Univ., Korea
17:25-17:35	Discussion

08:40-09:25

ENG Multimodal Imaging 1 (Joint Session with Korean Society of Echocardiography)

ACC

ENG Multimodal Imaging 1 (Joint Session with Korean Society of Echocardiography)

Mitral Stenosis in the Modern Era: Rheumatic Legacy, Calcific Challenge, Percutaneous Promise

Apr. 17 (Fri.) 08:40-09:25, 205

Chairpersons : Smonporn Boonyaratavej Songmuang , Geu-Ru Hong

Panel : Cynthia Taub , Jihoon Kim , Jae K. Oh

08:40-08:50	Rheumatic Mitral Stenosis: The Complimentary Role of Echo and CT
08:50-09:00	Degenerative Mitral Annular Calcification: The Complimentary Role of Echo and CT [Speaker] Chi Young Shim/Yonsei Univ., Korea
09:00-09:10	Multimodality Imaging Before and During Percutaneous Mitral Valve Intervention For MS [Speaker] Alex Lee/The Chiness Univ. of Hong Kong, Hong Kong
09:10-09:25	Panel Discussion With Audience Question and Answer

ENG Plenary 1 (INOCA/ANOCA: An Emerging Global Issue)

ACC

ENG Plenary 1 (INOCA/ANOCA: An Emerging Global Issue)

Apr. 17 (Fri.) 08:40-09:25, 300A

Chairpersons : Harlan M. Krumholz , Myung Ho Jeong

Panel : Kyung Il Park , Yuk Kong Lau , Kwan Seung Lee

08:40-08:50	Case Presentation: Two Different Types of ANOCA [Speaker] Seong-Bong Wee/Ulsan Univ., Korea
08:50-09:00	Clinical Outcomes and Approach to Management of INOCA/ANOCA [Speaker] Roxana Mehran/Icahn School of Medicine at Mount Sinai, USA
09:00-09:10	Managing INOCA/ANOCA in Li mited Resource Environments [Speaker] Rodney Jimenez/St. Luke's Medical Center - Global City, Philippines
09:10-09:25	Panel Discussion With Audience Question and Answer

09:35-10:20

ENG Special Topics 1 (Pediatric Cardiology: Prevention, Kawasaki Disease, and Lifelong Risk)

ACC

ENG Special Topics 1 (Pediatric Cardiology: Prevention, Kawasaki Disease, and Lifelong Risk)

Apr. 17 (Fri.) 09:35-10:20, 202

Chairpersons : Radityo Prakoso , I Seok Kang

Panel : Eugene Yang , Su-Jin Park , Jae Yoon Na

09:35-09:45	Prevention and Management of Long-term Cardiovascular Sequelae in Kawasaki Disease [Speaker] JinYoung Song/Sungkyunkwan Univ., Korea
09:45-09:55	RVOT Stenting and PDA Stenting in Late Presenter Congenital Heart Disease [Speaker] Radityo Prakoso/National Cardiovascular Centre Harapan Kita, Indonesia
09:55-10:05	Cardiovascular Risk in Grown-Up Congenital Heart Disease: Atherosclerosis and Beyond [Speaker] Ja Kyoung Yoon/Sungkyunkwan Univ., Korea
10:05-10:20	Panel Discussion With Audience Question and Answer

ENG Multimodal Imaging 2 (Joint Session with Korean Society of Echocardiography)

ACC

ENG Multimodal Imaging 2 (Joint Session with Korean Society of Echocardiography)

Seeing Through the Thickness: The Power of Multimodality Imaging

Apr. 17 (Fri.) 09:35-10:20, 205

Chairpersons : Goo-Yeong Cho , Cynthia Taub

Panel : Darae Kim , Seo Yeon Gwak , Jae K. Oh

09:35-09:45	Multimodality Imaging in the Assessment of Thickened Myocardium [Speaker] Jiwon Seo/Yonsei Univ., Korea
09:45-09:55	Multimodality Imaging in Amyloidosis [Speaker] William Kong/The National University Heart Centre Singapore, Singapore
09:55-10:05	Multimodality Imaging in Athlete’s Heart [Speaker] Jae Yeong Cho/Chonnam National Univ., Korea
10:05-10:20	Panel Discussion With Audience Question and Answer

ENG Cardiac Arrhythmias 1

ACC

ENG Cardiac Arrhythmias 1

Regional Differences in AFib Management

Apr. 17 (Fri.) 09:35-10:20, 300A

Chairpersons : Sootkeng Ma , Dae Hyeok Kim

Panel : Yae Min Park , Jun Beom Park , Andrea M. Russo

09:35-09:50	Early Rhythm Control: The New Paradigm for AFib [Speaker] Andrea M. Russo/Cooper Medical School of Rowan University, USA
09:50-09:57	Panel Discussion With Audience Question and Answer
09:57-10:12	Obesity: Lifestyle and Risk Factor Modification [Speaker] Ki Hong Lee/Chonnam National Univ., Korea
10:12-10:20	Panel Discussion With Audience Question and Answer

10:30-11:15

ENG Special Topics 2 (Women’s Heart Disease: Hormones, Rhythm, and Risk)

ACC

ENG Special Topics 2 (Women’s Heart Disease: Hormones, Rhythm, and Risk)

Apr. 17 (Fri.) 10:30-11:15, 202

Chairpersons : Roxana Mehran , Mi-Seung Shin

Panel : Junya Ako , Bonnie Ky , Mi Na Kim

10:30-10:40	Hormone Replacement Therapy and Heart Disease [Speaker] Pam R. Taub/UC San Diego Health, USA
10:40-10:50	Anticoagulation and Afib in Asian Women [Speaker] Yae Min Park/Gachon Univ., Korea
10:50-11:00	Rhythm Control Strategies in Women [Speaker] Andrea M. Russo/Cooper Medical School of Rowan University, USA
11:00-11:15	Panel Discussion With Audience Question and Answer

ENG Heart Failure and Cardiomyopathies 1 (Joint Society Session with Korean Society of Heart Failure)

ACC

ENG Heart Failure and Cardiomyopathies 1 (Joint Society Session with Korean Society of Heart Failure)

Heart Failure Management: Devices, AI, and Emerging Therapies

Apr. 17 (Fri.) 10:30-11:15, 205

Chairpersons : Jennifer A. Cowger , Hyun-Jai Cho

Panel : Mayanna Lund , Kaoru Dohi , Aekarach Ariyachaipanich

10:30-10:40	Emerging Devices in HFrEF Beyond CRT and LVAD [Speaker] Marat Fudim/Duke University, USA
10:40-10:45	Panel Discussion With Audience Question and Answer
10:45-10:55	Using Artificial Intelligence to Improve Heart Failure Outcomes [Speaker] Jin Joo Park/Seoul National Univ., Korea
10:55-11:00	Panel Discussion With Audience Question and Answer
11:00-11:10	Emerging Treatment Options for HFpEF [Speaker] Soo Yong Lee/Pusan National Univ., Korea
11:10-11:15	Panel Discussion With Audience Question and Answer

ENG Valvular Diseases and Structural Interventions 1

ACC

ENG Valvular Diseases and Structural Interventions 1

Valvular Interventions: Lessons from Challenging Cases

Apr. 17 (Fri.) 10:30-11:15, 300A

Chairpersons : Rodney Jimenez , Dae-Hee Kim

Panel : Sanjay Tyagi , In Sook Kang , Chan Soon Park

10:30-10:35	Case Presentation: My Worst Case in TAVR/TAVI, What I Learned [Speaker] Jung-Min Ahn/Ulsan Univ., Korea
10:35-10:45	Panel Discussion
10:45-10:50	Case Presentation: My Worst Case in Mitral TEER, What I Learned [Speaker] Eun Kyoung Kim/Sungkyunkwan Univ., Korea
10:50-11:00	Panel Discussion
11:00-11:05	Case Presentation: My Worst Case in Tricuspid TEER, What I Learned [Speaker] Ramesh Babu Daggubati/West Virginia University, USA
11:05-11:15	Panel Discussion

11:25-12:10

ENG Special Topics 3 (Genomics and Genetics in Cardiovascular Disease: From Cardiomyopathy to Dyslipidemia）

ACC

ENG Special Topics 3 (Genomics and Genetics in Cardiovascular Disease: From Cardiomyopathy to Dyslipidemia）

Apr. 17 (Fri.) 11:25-12:10, 202

Chairpersons : Seung Pyo Lee , Andrea M. Russo

Panel : Mayanna Lund , Kyung-Hee Kim , Inki Moon

11:25-11:35	Cardiomyopathy [Speaker] Lakshman Subrahmanyan/Dartmouth Hitchcock Medical Center, USA
11:35-11:45	Aortopathy [Speaker] Adeeb H. Al-Quthami/SUNY Upstate Medical University, USA
11:45-11:55	Genetics in Dyslipidemia [Speaker] Sang-Hak Lee/Yonsei Univ., Korea
11:55-12:10	Panel Discussion With Audience Question and Answer

ENG Heart Failure and Cardiomyopathies 2 (Joint Society Session with Korean Society of Heart Failure)

ACC

ENG Heart Failure and Cardiomyopathies 2 (Joint Society Session with Korean Society of Heart Failure)

Obesity, Inflammation, and Heart Failure: Treating the Whole Disease

Apr. 17 (Fri.) 11:25-12:10, 205

Chairpersons : Byung Su Yoo , Young Min Cho

Panel : Jennifer A. Cowger , Chan Joo Lee , Cynthia Taub

11:25-11:35	Obesity and Heart Failure: Understanding Cardiometabolism and Inflammation [Speaker] Jong-Chan Youn/Catholic Univ., Korea
11:35-11:40	Panel Discussion With Audience Question and Answer
11:40-11:50	Gut Inflammation and Heart Failure [Speaker] Melana Yuzefpolskaya/Columbia Presbyterian Irving Medical Center, USA
11:50-11:55	Panel Discussion With Audience Question and Answer
11:55-12:05	The Role of GLP1 in HFrEF and HFpEF [Speaker] Dong-Hyuk Cho/Korea Univ., Korea
12:05-12:10	Panel Discussion With Audience Question and Answer

ENG Valvular Diseases and Structural Interventions 2

ACC

ENG Valvular Diseases and Structural Interventions 2

Updates in the Guidelines: What to Know

Apr. 17 (Fri.) 11:25-12:10, 300A

Chairpersons : Ramesh Babu Daggubati , June Hong Kim

Panel : Jae hyun Lim , Sanjay Tyagi

11:25-11:35	Mixed Moderate AS and AR: To Intervene or to Wait [Speaker] Sung Ji Park/Sungkyunkwan Univ., Korea
11:35-11:45	Secondary MR: To Intervene or to Wait [Speaker] Kwan Seung Lee/Mayo Clinic Arizona, USA
11:45-11:55	Severe Secondary TR: To Intervene or to Wait [Speaker] Jun-Bean Park/Seoul National Univ., Korea
11:55-12:10	Panel Discussion With Audience Question and Answer

14:15-15:00

ENG Coronary Interventions and Ischemic Heart Diseases 1

ACC

ENG Coronary Interventions and Ischemic Heart Diseases 1

AI in Action: Transforming Coronary Intervention From Planning to Precision

Apr. 17 (Fri.) 14:15-15:00, 202

Chairpersons : Sanjay Tyagi , Jung-Sun Kim

Panel : Yuk Kong Lau , Doo Sun Sim , In Ho Yang

14:15-14:25	Beyond the FLASH Trial: Non-Intracoronary Based Imaging Artificial Intelligence for PCI Planning [Speaker] Yong Cheol Kim/Yonsei Univ., Korea
14:25-14:30	Panel Discussion With Audience Question and Answer
14:30-14:40	Artificial Intelligence in AMI ECG: Detecting Occlusion beyond STEMI [Speaker] Kwan Seung Lee/Mayo Clinic Arizona, USA
14:40-14:45	Panel Discussion With Audience Question and Answer
14:45-14:55	The Role of Artificial Intelligence in Intracoronary Imaging [Speaker] Jin Won Kim/Korea Univ., Korea
14:55-15:00	Panel Discussion With Audience Question and Answer

ENG Cardiovascular Disease Prevention 1 (Joint Session with Korean Society of Lipid and Atherosclerosis)

ACC

ENG Cardiovascular Disease Prevention 1 (Joint Session with Korean Society of Lipid and Atherosclerosis)

2025 Cholesterol Guidelines: Integration and Application in Asia

Apr. 17 (Fri.) 14:15-15:00, 205

Chairpersons : Ade Meidian Ambari , Sang-Hyun Kim

Panel : Hyun-Jin Kim , Hack-Lyoung Kim

14:15-14:25	Overview of 2025 ACC/AHA Blood Cholesterol Guideline [Speaker] Eugene Yang/University of Washington School of Medicine, USA
14:25-14:30	Discussion
14:30-14:40	Integration of the ACC/AHA Guideline Into Korean Dyslipidemia Management: KSoLA Perspective [Speaker] Youngwoo Jang/Gachon Univ., Korea
14:40-14:45	Discussion
14:45-14:55	Adoption of Lipid Guidelines in Asia: Challenges and Opportunities [Speaker] Minkwan Kim/Yonsei Univ., Korea
14:55-15:00	Discussion

ENG Heart Failure and Cardiomyopathies 3

ACC

ENG Heart Failure and Cardiomyopathies 3

Complex Cardiomyopathies: Diagnostic Innovations and Therapeutic Advances

Apr. 17 (Fri.) 14:15-15:00, 300A

Chairpersons : Kaoru Dohi , Byung-Hee Oh

Panel : Sunki Lee , In-Chang Hwang , Aekarach Ariyachaipanich

14:15-14:25	Amyloidosis [Speaker] Darae Kim/Sungkyunkwan Univ., Korea
14:25-14:30	Panel Discussion With Audience Question and Answer
14:30-14:40	Sarcoidosis [Speaker] Jennifer A. Cowger/Michigan State University, USA
14:40-14:45	Panel Discussion With Audience Question and Answer
14:45-14:55	Hypertrophic Cardiomyopathy [Speaker] Hyung-Kwan Kim/Seoul National Univ., Korea
14:55-15:00	Panel Discussion With Audience Question and Answer

15:10-15:55

Special Topics 4（Cardio-Oncology: Bridging Cancer and Cardiovascular Care）

ACC

Special Topics 4（Cardio-Oncology: Bridging Cancer and Cardiovascular Care）

Apr. 17 (Fri.) 15:10-15:55, 202

Chairpersons : Bonnie Ky , Il Suk Sohn

Panel : Mayanna Lund , Kaoru Dohi , Jeong-Eun Yi

15:10-15:20	Cardiovascular Effects of Common Cancer Therapies [Speaker] Bonnie Ky/University of Pennsylvania School of Medicine, USA
15:20-15:30	Evidence Based Strategies for Risk Prediction [Speaker] Yun Gyoo Lee/Sungkyunkwan Univ., Korea
15:30-15:40	Importance of Modifiable Cardiovascular Risk Factors in Our Patients With Cancer [Speaker] Hyukjin Park/Chonnam National Univ., Korea
15:40-15:55	Panel Discussion With Audience Question and Answer

ENG Cardiovascular Disease Prevention 2 (Joint Session with Korean Society of Lipid and Atherosclerosis)

ACC

ENG Cardiovascular Disease Prevention 2 (Joint Session with Korean Society of Lipid and Atherosclerosis)

Beyond Statins: Novel Therapies For Dyslipidemia and Cardiovascular Prevention

Apr. 17 (Fri.) 15:10-15:55, 205

Chairpersons : Sung Rae Kim , Eugene Yang

Panel : Jun-Hee Lee , Seonghoon Choi , Dae Young Cheon

15:10-15:20	PCSK9 Inhibition, From Monoclonal Antibodies to Small Molecules [Speaker] Kwon Oh Sung/Catholic Univ., Korea
15:20-15:25	Discussion
15:25-15:35	Bempedoic Acid, Expanding Options for Statin-Intolerant Patients [Speaker] Eugene Yang/University of Washington School of Medicine, USA
15:35-15:40	Discussion
15:40-15:50	Next-Generation Therapies Targeting Lipoprotein(a) and Apolipoprotein B- The Promise of ASO and siRNA Platforms [Speaker] Jin Wi/Gachon Univ., Korea
15:50-15:55	Discussion

ENG Valvular Diseases and Structural Interventions 3

ACC

ENG Valvular Diseases and Structural Interventions 3

Asymptomatic Severe Valve Disease: Evidence and Decision-Making

Apr. 17 (Fri.) 15:10-15:55, 300A

Chairpersons : Geu-Ru Hong , Roxana Mehran

Panel : Ramesh Babu Daggubati , Yeonyee E. Yoon , Jung Hyun Choi

15:10-15:15	Case Presentation: Asymptomatic Primary MR [Speaker] Ye Chan Kim/Sungkyunkwan Univ., Korea
15:15-15:25	Asymptomatic MR: A Dive into Evidence [Speaker] Seung Pyo Lee/Seoul National Univ., Korea
15:25-15:30	Case Presentation: Asymptomatic Severe Aortic Stenosis [Speaker] Sang Hyun Kim/Catholic Univ., Korea
15:30-15:40	Asymptomatic AS: A Dive into Evidence [Speaker] Ramesh Babu Daggubati/West Virginia University, USA
15:40-15:55	Panel Discussion With Audience Question and Answer

16:05-16:50

ENG Coronary Interventions and Ischemic Heart Diseases 2 (Joint Session with Korean Society of Interventional Cardiology)

ACC

ENG Coronary Interventions and Ischemic Heart Diseases 2 (Joint Session with Korean Society of Interventional Cardiology)

Breaking Barriers in Complex High-Risk PCI: Innovations and Strategies

Apr. 17 (Fri.) 16:05-16:50, 205

Chairpersons : Sanjay Tyagi , Youngkeun Ahn

Panel : Joo-Yong Hahn , Jung-Sun Kim , Kwan Seung Lee

16:05-16:15	Advances in Managing Calcified, Balloon Non-crossable Lesions [Speaker] Kwan Seung Lee/Mayo Clinic Arizona, USA
16:15-16:20	Panel Discussion With Audience Question and Answer
16:20-16:30	Hybrid Bifurcation Approaches With Drug-Coated Balloons [Speaker] Ae-Young Her/Kangwon National Univ., Korea
16:30-16:35	Panel Discussion With Audience Question and Answer
16:35-16:45	Mechanical Circulatory Support in High-Risk PCI [Speaker] Ramesh Babu Daggubati/West Virginia University, USA
16:45-16:50	Panel Discussion With Audience Question and Answer

ENG Plenary 2 (Leveraging AI in EMR and Beyond)

ACC

ENG Plenary 2 (Leveraging AI in EMR and Beyond)

Apr. 17 (Fri.) 16:05-16:50, 300A

Chairpersons : Eugene Yang , Yong-Jin Kim

Panel : Cynthia Taub , William Kong , Jun Hwan Cho

16:05-16:20	US Perspective: How to Leverage AI in the EMR Environment [Speaker] Harlan M. Krumholz/Yale School of Medicine, USA
16:20-16:35	Korean Perspective: How to Leverage AI in the EMR Environment [Speaker] Seng Chan You/Yonsei Univ., Korea
16:35-16:50	Panel Discussion With Audience Question and Answer

17:00-17:45

ENG Coronary Interventions and Ischemic Heart Diseases 3 (Joint Session with Korean Society of Interventional Cardiology)

ACC

ENG Coronary Interventions and Ischemic Heart Diseases 3 (Joint Session with Korean Society of Interventional Cardiology)

Inside the Vessel: Advanced Imaging and Physiology For Complex PCI

Apr. 17 (Fri.) 17:00-17:45, 205

Chairpersons : Bon-Kwon Koo , Kin-Lam Tsui

Panel : Roxana Mehran , Hyuck-Jun Yoon , Jung-Min Ahn

17:00-17:10	Understanding Intracoronary Physiology Discrepancies in Hyperemic vs Non-Hyperemic Modalities [Speaker] Janghoon Lee/Kyungpook National Univ., Korea
17:10-17:15	Panel Discussion With Audience Question and Answer
17:15-17:25	Beyond RENOVATE-COMPLEX PCI: Future Directions for Intracoronary Imaging [Speaker] Joo Myung Lee/Sungkyunkwan Univ., Korea
17:25-17:30	Panel Discussion With Audience Question and Answer
17:30-17:40	How Will CABG Compare With Standardized Best Practice Contemporary Multi-vessel PCI [Speaker] Kwan Seung Lee/Mayo Clinic Arizona, USA
17:40-17:45	Panel Discussion With Audience Question and Answer

ENG FIT Jeopardy: The Classic Game Show With a FIT Twist!

ACC

ENG FIT Jeopardy: The Classic Game Show With a FIT Twist!

Apr. 17 (Fri.) 17:00-17:45, 300A

Host : Eugene Yang

Panel : Yuk Kong Lau

17:00-17:45	Teams: South Korea, Philippines, China and Singapore

4.18 Sat.

08:00-09:30

Cardiogenic Shock

KSC

Cardiogenic Shock

Modern Management of Cardiogenic Shock

Apr. 18 (Sat.) 08:00-09:30, 102

Chairpersons : Myeong-Chan Cho , Cheol Woong Yu

Panel : Ah Ram Kim , Ji Hoon Kim , Dae Hwan Bae , Chul-Min Ahn , Ji Hyun Cha

Learning Objective: 1. To recognize and stage cardiogenic shock using contemporary diagnostic and risk stratification frameworks.
2. To apply phenotype-based pharmacologic strategies and identify the limits of medical therapy in cardiogenic shock.
3. To select appropriate mechanical circulatory support in AMI-related cardiogenic shock, with a practical comparison of Impella and VA-ECMO.

08:00-08:15	Early Recognition and Risk Stratification of Cardiogenic Shock [Speaker] Jin Ho Lee/Kyung Hee Univ., Korea
08:15-08:30	Hemodynamic Phenotypes of Cardiogenic Shock [Speaker] Bum Sung Kim/Konkuk Univ., Korea
08:30-08:45	Pharmacologic Management of Cardiogenic Shock [Speaker] Min Chul Kim/Chonnam National Univ., Korea
08:45-09:00	Impella vs. VA-ECMO in AMI-Related Cardiogenic Shock [Speaker] Jeong Hoon Yang/Sungkyunkwan Univ., Korea
09:00-09:15	Shock Team & Shock Center: Does System Matter? [Speaker] Jeehoon Kang/Seoul National Univ., Korea
09:15-09:30	Discussion

Cardiac Surgery

KSC

Cardiac Surgery

A Deadly Duo: Valvular Heart Disease and Atrial Fibrillation

Apr. 18 (Sat.) 08:00-09:30, 104

Chairpersons : Hyung Gon Je , Sak Lee

Panel : Hong-rae Kim , Soojin Park , Hanjin Park , Won-kyeong Pyo

Learning Objective: 1. To review the latest guidelines and clinical evidence on valvular atrial fibrillation.
2. To understand anticoagulation therapy for valvular atrial fibrillation.
3. To explore the advantages and disadvantages of concomitant surgery for valvular disease and atrial fibrillation, as well as the effectiveness of left atrial appendage excision.

08:00-08:15	The Paradigm Shift in Valvular AF: Contemporary Guidelines and Evidence [Speaker] Daehoon Kim/Yonsei Univ., Korea
08:15-08:30	Anticoagulation Strategies in Valvular AF: Beyond Warfarin [Speaker] Jaemin Shim/Korea Univ., Korea
08:30-08:45	Impact of Surgical Maze Procedure on Survival and Stroke Prevention in Valvular AF [Speaker] Ho Jin Kim/Ulsan Univ., Korea
08:45-09:00	Restorin Sinus Rhythm: Clinical Efficacy of Surgery in Valvular AF Patients [Speaker] Sun Kyun Ro/Hanyang Univ., Korea
09:00-09:15	Left Atrial Appendage Exclusion Strategies in Valvular AF [Speaker] Suryeun Chung/Sungkyunkwan Univ., Korea
09:15-09:30	Discussion

KSE 2

KSE

KSE 2

Imaging-Guided Approach to Cardiomyopathies: From Diagnosis to Treatment Guidance

Apr. 18 (Sat.) 08:00-09:30, 105

Chairpersons : Ji Yong Choi , Yong-Jin Kim

Panel : Hyue Mee Kim , Jong Ho Nam , Ju-Hee Lee , Ji-Won Hwang

08:00-08:20	Echo Red Flags: When to Suspect Cardiomyopathies Rather Than Concentric LVH [Speaker] Sung-Hee Shin/Inha Univ., Korea
08:20-08:40	Multimodality Imaging in Suspected Cardiomyopathy: When to Go Beyond Echocardiography [Speaker] Eui-Young Choi/Yonsei Univ., Korea
08:40-09:00	Imaging-Guided Assessment of Treatment Response in Cardiomyopathy: HCM [Speaker] Sahmin Lee/Ulsan Univ., Korea
09:00-09:20	Imaging-Guided Assessment of Treatment Response in Cardiomyopathy: RCM [Speaker] Jino Park/Inje Univ., Korea
09:20-09:30	Discussion

ENG Vascular Research 1

KSC

ENG Vascular Research 1

2026 How to Measure Vascular Health

Apr. 18 (Sat.) 08:00-09:30, 203

Chairpersons : Ki Chul Sung , Byoung Kwon Lee

Panel : Suk Min Seo , Heesun Lee , Hyemoon Chung , Jun Hwan Cho , Seok-Jae Hwang

Learning Objective: 1. To understand the conceptual framework for assessing vascular health with a focus on aortic stiffness, and to explain the limitations of traditional blood pressure?centered evaluation.
2. To understand how various vascular function indices-including hemorheology, microvascular function, and imaging-based assessments-account for residual cardiovascular risk.
3. To critically evaluate the clinical significance and real-world applicability of emerging vascular health assessment methods utilizing imaging, AI, and digital health technologies.

08:00-08:15	Aortic Stiffness as the Foundation of Vascular Health Assessment [Speaker] Jaehoon Chung/Dongguk Univ., Korea
08:15-08:30	Rheology as a Missing Link in Cardiovascular Disease [Speaker] Young-Hoon Jeong/Chung-Ang Univ., Korea
08:30-08:45	Imaging-based Assessment of Vascular Health [Speaker] Wei-Chun Huang/Pingtung Christian Hospital National Sun Yat-sen University, Taiwan
08:45-09:00	Residual Vascular Risk: Why Events Occur Despite Good Control [Speaker] Nuntakorn Thongtang/Mahidol University, Thailand
09:00-09:15	AI and Digital Health for Vascular Health [Speaker] SungA Bae/Yonsei Univ., Korea
09:15-09:30	Discussion

KSIC 2

KSIC

KSIC 2

Managing Coronary Calcification in PCI

Apr. 18 (Sat.) 08:00-09:30, 300B

Chairpersons : Hyeon Cheol Gwon , Hee-Yeol Kim

Panel : Byeong-Keuk Kim , Chang-Wook Nam , Bong-Ki Lee , Young-Hyo Lim , Young Joon Hong

Learning Objective: 1. 관상동맥 석회화 병변에서 PCI를 시행할 때 석회화의 형태와 분포에 따른 치료 전략의 차이를 살펴봅니다.
2. 최신 근거와 증례를 통해 적절한 기기 선택과 intravascular imaging의 중요성을 살펴보고자 합니다.

08:00-08:15	Understanding Coronary Calcium: Morphology, Distribution, and Clinical Implications [Speaker] Dong-Kie Kim/Inje Univ., Korea
08:15-08:30	Morphology-Based Device Selection and Procedural Techniques: Rotational Atherectomy [Speaker] Namkyun Kim/Kyungpook National Univ., Korea
08:30-08:45	Morphology-Based Device Selection and Procedural Techniques: Orbital Atherectomy [Speaker] Kwan Yong Lee/Catholic Univ., Korea
08:45-09:00	Morphology-Based Device Selection and Procedural Techniques: IVL [Speaker] Young Bin Song/Sungkyunkwan Univ., Korea
09:00-09:15	Intravascular Imaging-Guided Calcium Assessment and Optimization [Speaker] Sang Yeub Lee/Chung-Ang Univ., Korea
09:15-09:30	Discussion

Education Workshop 1 - Arrhythmia

KSC

Education Workshop 1 - Arrhythmia

Recent Therapeutic Approaches in Arrhythmias

Apr. 18 (Sat.) 08:00-09:30, 300C

Chairpersons : Myung-Yong Lee , Seil Oh

Panel : Min Kim , Yeji Kim , Yoon Jung Park , Tae Wan Chung

Learning Objective: 1. To understand the latest concepts and clinical significance of physiologic atrial and ventricular pacing.
2. To review the evidence and clinical applicability of the latest ablation energy sources and technologies beyond atrial fibrillation.
3. To understand the clinical implications of genetic diagnosis, risk stratification, and personalized treatment strategies based on the latest concepts in inherited channelopathies.

08:00-08:15	Current Status of Physiologic Pacing: Bachmann's Bundle Pacing and Left Bundle Branch Pacing [Speaker] Min Soo Cho/Ulsan Univ., Korea
08:15-08:30	Current Status of Leadless Pacemakers: Devices, Indications, and Limitations [Speaker] Jong Min Hwang/Keimyung Univ., Korea
08:30-08:45	Evolution of Technologies for AF Ablation [Speaker] Dae In Lee/Korea Univ., Korea
08:45-09:00	Mapping and Ablation Technologies for Ventricular Arrhythmia [Speaker] Jae-Sun Uhm/Yonsei Univ., Korea
09:00-09:15	Inherited Channelopathies [Speaker] Young Choi/Catholic Univ., Korea
09:15-09:30	Discussion

09:50-11:20

Cardiovascular Genome and Precision Medicine

KSC

Cardiovascular Genome and Precision Medicine

Deep Dive to Genetic Testing, What, When, How & Who?

Apr. 18 (Sat.) 09:50-11:20, 102

Chairpersons : Duk Kyung Kim , Sang-Hak Lee

Panel : Mi Joo Kim , Inki Moon , Mi-Hyun Park , Jooyeon Lee

Learning Objective: 1. To review the basics of genetic testing.
2. To review when to perform genetic testing, how to interpret the results, and the clinical situations in which WES/WGS are indicated.

09:50-10:10	When Do I Check Genetic Rest? [Speaker] Jaewon Oh/Yonsei Univ., Korea
10:10-10:30	How to Interpret Genetic Test Report? [Speaker] Man Jin Kim/Seoul National Univ., Korea
10:30-10:50	Who Need Whole Exome/Genome Sequencing? [Speaker] Go Hun Seo/3Billion, Korea
10:50-11:20	Discussion

ENG KPHS 1

KPHS

ENG KPHS 1

Rethinking 'Simple' Heart Defects: Advances in Diagnosis and Treatment

Apr. 18 (Sat.) 09:50-11:20, 104

Chairpersons : Jo Won Jung , Cheul Lee

Panel : Yujin Kwak , Hye Won Kwon , Eung Re Kim , Jae Hong Lim , Gwang-Jun Choi

Learning Objective: 1. To review long-term complications and key considerations during follow-up in common but clinically important simple congenital heart diseases.
2. To determine the appropriate duration of follow-up after treatment of ASD, VSD, or small VSD, and to identify potential complications to monitor.
3. To discuss surgical and interventional treatment strategies for simple congenital heart disease, including surgery versus intervention.

09:50-10:05	VSD(Ventricular Septal Defect) - Have We Figured It Out Yet? [Speaker] Leo Lopez/Stanford Univ., USA
10:05-10:20	The Fate of VSD: How Long Should We Follow-up? - Small VSD vs Repaired VSD [Speaker] Lucy Youngmin Eun/Yonsei Univ., Korea
10:20-10:35	The Fate of Repaired ASD: How Long Should We Follow-up? [Speaker] Jihye You/Jeonbuk National Univ., Korea
10:35-10:50	Surgical Perspectives on “Simple” Congenital Heart Defects: Are They Really Simple? [Speaker] Chun Soo Park/Ulsan Univ., Korea
10:50-11:05	Contemporary Catheter-Based Strategies for Simple Congenital Heart Defects [Speaker] Seulgi Cha/Ulsan Univ., Korea
11:05-11:20	Discussion

ENG KSE 3

KSE

ENG KSE 3

Echo on the Frontlines: Here, There, and Everywhere

Apr. 18 (Sat.) 09:50-11:20, 105

Chairpersons : Hae Ok Jung , Goo-Yeong Cho

Panel : Dae-Young Kim , Jin Kyung Oh , Nuri Lee , In-Chang Hwang , Alex Lee

09:50-10:10	AI-Powered Echo: Bridging the Gap from Labs to the Frontlines [Speaker] Jae K. Oh/Mayo Clinic, USA
10:10-10:30	Echo in the Oncology Clinic: Safeguarding the Heart [Speaker] Woo-Baek Chung/Catholic Univ., Korea
10:30-10:50	Echo in the ICU: Bedside Decisions in Critical Care [Speaker] Cynthia Taub/SUNY Upstate Medical University, USA
10:50-11:10	Echo in the Stroke Unit: Cardiac Clues Behind Stroke [Speaker] Mi Na Kim/Korea Univ., Korea
11:10-11:20	Discussion

KSHF 2

KSHF

KSHF 2

Advanced Therapies, Palliation, and Human Dignity in Stage D Heart Failure

Apr. 18 (Sat.) 09:50-11:20, 203

Chairpersons : Dae-Gyun Park , Byung Su Yoo

Panel : In-Cheol Kim , Minjae Yoon , Sunki Lee , Sung-Ho Jung

Learning Objective: 1. Stage D 심부전에서 LVAD의 발전에 따라서 Benefit을 얻을 환자 Burden만 될 환자를 selection를 하는 것도 변화되고 최신 업데이트된 데이터를 통해 함께 논의해봅니다.
2. Stage D 심부전에서 적극적 치료의 한계를 인식하고, 완화의료(palliative care)를 포함한 환자 중심 치료 전략을 임상 상황에 맞게 선택할 수 있습니다.
3. 심부전 환자의 완화의료가 어떻게 정책에 반영되어야 할지에 대해서 논의합니다.

09:50-10:05	[ENG] Up-to-Date Management of Stage D HF in Asia [Speaker] Michael Ka Lam Wong/Cardiac Medical Unit, Grantham Hospital, Hong Kong
10:05-10:20	[KOR] LVAD in Korea: Insight from the Korean Registry [Speaker] Jin Oh Choi/Sungkyunkwan Univ., Korea
10:20-10:35	[KOR] Palliative Care in End-Stage Heart Failure [Speaker] Hae-Young Lee/Seoul National Univ., Korea
10:35-10:50	[KOR] ICD Deactivation in End-Stage Heart Failure: Ethical and Clinical Considerations [Speaker] Ah Ram Kim/Ulsan Univ., Korea
10:50-11:05	[KOR] How to Apply Palliative Care/Hospice in Heart Failure Patients [Speaker] Shin Hye Yoo/Seoul National Univ., Korea
11:05-11:20	Discussion

Smart Health

KSC

Smart Health

Human-AI Collaboration in Cardiovascular Digital Health Care: Opportunities, Limits, and Trust

Apr. 18 (Sat.) 09:50-11:20, 300B

Chairpersons : Young Hak Kim , Hyun-Jae Kang

Panel : Yong Cheol Kim , Seung-Jun Lee , Youngjin Cho , Jong-Il Choi

Learning Objective: 1. This session is designed to provide an overview of the latest trends in AI and digital health.
2. It will also explore philosophical perspectives, including the future societal roles of humans and AI, as well as the reliability of AI.

09:50-10:05	AI in Cardiac Image Acquisition and Analysis: Current Developments [Speaker] Hyuk-Jae Chang/Yonsei Univ., Korea
10:05-10:20	Advancements in AI ECG [Speaker] Kyung Soo Kim/Medical AI, Korea
10:20-10:35	Wearable Devices: Current Status and Future Perspectives [Speaker] Yun Gi Kim/Korea Univ., Korea
10:35-10:50	Human Doctors vs. AI for Clinical Consultation [Speaker] Ju-Seung Kwun/Seoul National Univ., Korea
10:50-11:05	Credibility of AI [Speaker] Chung Ki Kim/Ewha Womans Univ., Korea
11:05-11:20	Discussion

Education Workshop 2 - Hypertension

KSC

Education Workshop 2 - Hypertension

Recent Issues in Hypertension

Apr. 18 (Sat.) 09:50-11:20, 300C

Chairpersons : Sang Hyun Ihm , Seung-Woon Rha

Panel : Sung Soo Kim , Il Suk Sohn , Jeong-Hun Shin , Janghoon Lee

Learning Objective: 1. To review the key aspects of diagnosis and treatment.
2. To explore the latest trends and developments in hypertension.

09:50-10:05	Core Essentials of the Clinical Practice Guideline [Speaker] Eun Mi Lee/Dongguk Univ., Korea
10:05-10:20	Importance of out-of-office BP Monitoring [Speaker] Joong Wha Chung/Chosun Univ., Korea
10:20-10:35	AI-driven Personalized Management in Hypertension [Speaker] SungA Bae/Yonsei Univ., Korea
10:35-10:50	Management Strategies for Resistant Hypertension [Speaker] Jin Oh Na/Korea Univ., Korea
10:50-11:05	Fixed Initial Low-dose Triple or Quadruple Combination Therapy for Hypertension [Speaker] Sung Ha Park/Yonsei Univ., Korea
11:05-11:20	Discussion

11:40-12:20

Scientific Session [Daiichi Sankyo/Daewoong]

KSC

Scientific Session [Daiichi Sankyo/Daewoong]

Evidence-Based Management of Atrial Fibrillation and Hypertension

Apr. 18 (Sat.) 11:40-12:20, 105

Chairpersons : Hyung Wook Park , Seonghoon Choi

11:40-12:00	Evidence-Based Anticoagulation in Elderly AF [Speaker] Chan Hee Lee/Yeungnam Univ., Korea
12:00-12:20	Optimizing Hypertension Treatment with Olmesartan BP Control & CV Protection [Speaker] Hack-Lyoung Kim/Seoul National Univ., Korea

Scientific Session [JW Pharm]

KSC

Scientific Session [JW Pharm]

Strategic Management for Cardiovascular Prevention: Balancing Efficacy and Safety

Apr. 18 (Sat.) 11:40-12:20, 203

Chairpersons : Sang Hyun Ihm , Chul Soo Park

11:40-12:00	Cutting Egde Care of Pitavastatin with Ezetimibe Combination Therapy [Speaker] Eun Ho Choo/Catholic Univ., Korea
12:00-12:20	Integrated Management of Hypertension and Dyslipidemia for Cardiovascular Disease Prevention [Speaker] Hyo Suk Ahn/Catholic Univ., Korea

Scientific Session [Viatris]

KSC

Scientific Session [Viatris]

From Risk Recognition to Therapeutic Decision: Statin Selection Beyond LDL-C

Apr. 18 (Sat.) 11:40-12:20, 300B

Chairpersons : Jin-Ok Jeong , Joo-Yong Hahn

11:40-12:00	Effective Therapies for High-Risk Dyslipidemia Patients Who Need Aggressive LDL-C Lowering [Speaker] Do-Yoon Kang/Ulsan Univ., Korea
12:00-12:20	Consideration of Renal Safety in Dyslipidemia Patients: Why It's Essential [Speaker] Jeehoon Kang/Seoul National Univ., Korea

Scientific Session [Sky Labs]

KSC

Scientific Session [Sky Labs]

Cuffless BP Monitoring: Evidence to Experience

Apr. 18 (Sat.) 11:40-12:20, 300C

Chairpersons : Seok-Min Kang , Kwang-il Kim

11:40-12:00	Cuffless BP Monitoring and Current Guidelines: Where Are We Now? [Speaker] Jeong Hoon Yang/Sungkyunkwan Univ., Korea
12:00-12:20	Clinical Evidence of CART BP in Routine Hypertension Care: Where Do We Go? [Speaker] Jeong-Hun Shin/Hanyang Univ., Korea

ENG Special Topics 5 (Women in Cardiology: Pathways to Success and Leadership)

ACC

ENG Special Topics 5 (Women in Cardiology: Pathways to Success and Leadership)

Apr. 18 (Sat.) 11:40-12:20, 202

Chairpersons : Il Suk Sohn , Mayanna Lund

Panel : Seong-Mi Park , Roxana Mehran , Bonnie Ky , Andrea M. Russo , Cynthia Taub

Scientific Session [Yuhan]

KSC

Scientific Session [Yuhan]

The New Era of Lipid Management: Translating 2026 ACC/AHA Guidelines into Practice with Rosuvastatin Plus Ezetimibe for Intensive LDL-C Targeting

Apr. 18 (Sat.) 11:40-12:20, 205

Chairpersons : In-Ho Chae , Byeong-Keuk Kim

11:40-12:00	Evolution of Dyslipidemia Guidelines with the 2026 ACC/AHA Updates: Finding the Role of Rosuvastatin Plus Ezetimibe [Speaker] Jae Hyoung Park/Korea Univ., Korea
12:00-12:20	Paving the Road for Optimal LDL-C Management: New Evidence on Intensive LDL-C Targeting [Speaker] Yong-Joon Lee/Yonsei Univ., Korea

Scientific Session [Celltrion Pharm/Daewon]

KSC

Scientific Session [Celltrion Pharm/Daewon]

Strategies for Managing Hypertension

Apr. 18 (Sat.) 11:40-12:20, 300A

Chairpersons : Byung Su Yoo , Sung Ha Park

11:40-12:00	What to Consider for 24hr BP Control [Speaker] Dae-Hee Kim/Ulsan Univ., Korea
12:00-12:20	Advanced Combination Therapy in Hypertension: The Role of Azilsartan-Amlodipine [Speaker] Chan Joo Lee/Yonsei Univ., Korea

12:35-14:05

KSoLA 2

KSoLA

KSoLA 2

Beyond LDL-C: residual risk and competing priorities

Apr. 18 (Sat.) 12:35-14:05, 102

Chairpersons : Donghoon Choi , Sang-Hak Lee

Panel : Jae Hyoung Park , Jun Hwa Hong , Jung-Joon Cha , Hyun Sung Joh

Learning Objective: 1. LDL-C 목표 도달 이후 남는 잔여위험과 Lp(a), oxidized phospholipids의 역할 및 잠정적 치료 전략을 이해한다.
2. 중성지방 및 잔여콜레스테롤 표적 치료에서 ANGPTL3, APOC3 억제제의 기전, 임상 근거, 잠재적 적용 환자군을 정리한다.
3. hs-CRP가 높은 환자에서 염증 표적 치료와 지질강하 치료의 우선순위와 병용 및 순차 투여 전략을 비교한다.

12:35-12:55	Lp(a) and oxidized phospholipids: what to do while we wait for dedicated therapies [Speaker] Janghoon Lee/Kyungpook National Univ., Korea
12:55-13:15	ANGPTL3 and APO3 inhibition for Triglyceride-rich lipoproteins and remnant cholesterol [Speaker] Jae Hyun Bae/Seoul National Univ., Korea
13:15-13:35	Inflammation vs lipids: sequencing therapies when hs-CRP is high [Speaker] Jong Shin Woo/Kyung Hee Univ., Korea
13:35-13:55	Discussion

ENG KPHS 2

KPHS

ENG KPHS 2

Left-sided Valve Issues in Congenital Heart Diseases

Apr. 18 (Sat.) 12:35-14:05, 104

Chairpersons : Tae Gook Jun , Hyoung Doo Lee

Panel : Chang Sin Kim , Hyungtae Kim , Joo Won Lee , Woo Seong Chang , Hwa Jin Cho

Learning Objective: 1. To review imaging assessment methods and the indications for medical and surgical management of left-sided congenital valvular heart disease.
2. To review surgical treatment strategies and outcomes of left-sided congenital valvular heart disease.
3. Through this session, we aim to reach a consensus on the management of left-sided heart disease in pediatric and adolescent patients.

12:35-12:50	3D Echo and Advanced Imaging Evaluation of the Congenital Atrioventricular Valve Diseses [Speaker] Leo Lopez/Stanford Univ., USA
12:50-13:05	Left-Sided Valve Challenges in Pediatric Patients: When to Intervene? [Speaker] Seung Min Baek/Seoul National Univ., Korea
13:05-13:20	Mitral Valve Reconstruction in CHD(Congenital Heart Disease): Selection of Surgical Strategies & Durability [Speaker] Yu Rim Shin/Yonsei Univ., Korea
13:20-13:35	Aortic Valve Repair in Congenital Heart Disease: Growth-Compatible Techniques and Long-Term Durability [Speaker] Eun Seok Choi/Ulsan Univ., Korea
13:35-13:50	Atrioventricular Valve Management in Single Ventricle: Surgical Indication and Outcome [Speaker] Ji-Hyuk Yang/Sungkyunkwan Univ., Korea
13:50-14:05	Discussion

KHRS3-CIED

KHRS

KHRS3-CIED

Optimal Strategies for Cardiac Pacing Therapy: From Physiologic Pacing to Long-Term Complication Management (Case-Based)

Apr. 18 (Sat.) 12:35-14:05, 105

Chairpersons : Yong Seog Oh , Jong-Il Choi

Panel : Kyung-Yeon Lee , Young Soo Lee , Ji Hyun Lee , Sung Il Im , Yun Young Choi

Learning Objective: 1. 다양한 심방 페이싱 위치(Atrial Pacing Sites)의 생리학적 이점을 이해하고, 특히 Bachmann Bundle Pacing의 임상 적용을 고려할 수 있다.
2. Conduction System Pacing (CSP)시술에 있어서 환자 특성 (적응증, 해부학적 특성 [chamber size, structural heart disease 동반 여부 등]) 에 따라 시술 성공률을 높일 수 있는 맞춤형 시술 전략을 논의한다.
3. Leadless Pacemaker (LPM)의 장점과 한계를 이해하고, Leadless VDD/LPM-CRT 등 발전된 기술을 기반으로 LPM을 고려해야 할 명확한 환자군을 선별할 수 있다.
4. 장기 박동기 환자 추적관찰 중 발생하는 심부전(PICM 포함)과 삼첨판 역류증(TR)의 발생 기전을 설명하고, 약물 치료, CRT 업그레이드, 경피적 삼첨판 시술 등을 포함한 포괄적인 관리 전략을 증례 기반으로 수립할 수 있다.

12:35-12:50	Atrial pacing lead, where is the optimal site for its placement? [Speaker] Jong Min Hwang/Keimyung Univ., Korea
12:50-13:05	Are there patient-specific tailored strategies for CSP implantation? [Speaker] Young Jun Park/Korea Univ., Korea
13:05-13:20	In which patients should a leadless pacemaker be considered? [Speaker] In-Soo Kim/Yonsei Univ., Korea
13:20-13:35	CIEDs in the Operating Room: Which Complications Require Surgical Management? [Speaker] Yoonjin Kang/Seoul National Univ., Korea
13:35-13:50	How should we manage heart failure and tricuspid valve regurgitation that develop during the follow-up of pacemaker patients? [Speaker] Sung Soo Kim/Chosun Univ., Korea
13:50-14:05	Discussion

Vascular Research 2

KSC

Vascular Research 2

2026 How to Manage Peripheral Artery Disease

Apr. 18 (Sat.) 12:35-14:05, 203

Chairpersons : Moo-Yong Rhee , Eun Joo Cho

Panel : Su Hong Kim , Young Jin Youn , Seung-Jae Lee , Jae-Hwan Lee , Jeonghwan Cho

Learning Objective: 1. To understand peripheral artery disease as a manifestation of systemic vascular disease rather than a localized lower extremity condition, and to explain its clinical significance from a prognostic perspective.
2. To recognize the limitations of diagnostic tools, including the ankle-brachial index (ABI), and to assess disease severity and treatment needs by integrating symptoms and functional evaluation.
3. To distinguish the appropriate timing for guideline-based pharmacologic therapy, exercise therapy, and revascularization strategies, and to select treatment approaches based on individual patient characteristics.

12:35-12:50	Guideline-Based Management of Peripheral Artery Disease [Speaker] Ju-Seung Kwun/Seoul National Univ., Korea
12:50-13:05	Redefining PAD: A Marker of Systemic Vascular Disease [Speaker] Kang-Un Choi/Yeungnam Univ., Korea
13:05-13:20	How to Diagnose and Functionally Assess Peripheral Artery Disease [Speaker] Taek Kyu Park/Sungkyunkwan Univ., Korea
13:20-13:35	When and How to Revascularize: Choosing the Right Strategy for the Right Patient [Speaker] Ji Yong Jang/National Health Insurance Service Ilsan Hospital, Korea
13:35-13:50	Why Exercise Matters in Peripheral Artery Disease [Speaker] Jong-Young Lee/Hallym Univ., Korea
13:50-14:05	Discussion

KSIC 3

KSIC

KSIC 3

Cross Specialty: Cutting-Edge Issues in TAVR 2026

Apr. 18 (Sat.) 12:35-14:05, 300B

Chairpersons : In-Ho Chae , Young-Guk Ko

Panel : Eun Kyoung Kim , Duk-Woo Park , Tae-Hyun Yang , Sang Rok Lee , Cheol Hyun Lee

Learning Objective: This session offers a valuable opportunity to review and discuss the key issues currently at the forefront of the TAVR field as of 2026.
Focusing on recently published cutting-edge research, the session will explore evolving paradigms in TAVR practice and provide insights into future directions of the field.

12:35-12:50	To PCI or Not to PCI: Obstructive CAD in the Peri-TAVR Setting [Speaker] Byung Hee Hwang/Catholic Univ., Korea
12:50-13:05	Minimally Invasive Surgical Explantation for Failed TAVR Valves [Speaker] Jae Suk Yoo/Ulsan Univ., Korea
13:05-13:20	Optimal Antithrombotic Therapy after TAVR: With or Without Indication for Anticoagulation [Speaker] Do-Yoon Kang/Ulsan Univ., Korea
13:20-13:35	Long-Term Performance and Durability of TAVR Valves [Speaker] Sung Jin Hong/Yonsei Univ., Korea
13:35-13:50	TAVR in Low-Flow, Low-Gradient Aortic Stenosis: Indications and Outcomes [Speaker] Jung-Kyu Han/Seoul National Univ., Korea
13:50-14:05	Discussion

Education Workshop 3 - Heart Failure

KSC

Education Workshop 3 - Heart Failure

Diagnosis and Treatment Beyond HFrEF

Apr. 18 (Sat.) 12:35-14:05, 300C

Chairpersons : Byung Su Yoo , Kye Hun Kim

Panel : Jung-Woo Son , Mi-Hyang Jung , Dong-Hyuk Cho , Jae Yeong Cho

Learning Objective: 1. To understand the key echocardiographic features for the diagnosis and differentiation of ATTR cardiomyopathy and hypertrophic cardiomyopathy, and to recognize their clinical role and value.
2. To be familiar with the key parameters and principles for assessing diastolic function based on the latest guidelines, and to apply them in various clinical settings.
3. To understand the major updates and key messages of the latest valvular heart disease guidelines, and to incorporate echocardiography-based severity assessment into clinical decision-making.

12:35-12:50	박출률보존심부전의 진단과 치료 [Speaker] Bong Joon Kim/Kosin Univ., Korea
12:50-13:05	우심부전의 진단과 치료 [Speaker] Soo Yong Lee/Pusan National Univ., Korea
13:05-13:20	좌심실보조장치의 이해 [Speaker] Darae Kim/Sungkyunkwan Univ., Korea
13:20-13:35	대표적인 유전자 관련 심근증 [Speaker] Sang Eun Lee/Ulsan Univ., Korea
13:35-13:50	심부전에 동반된 관상동맥 질환의 진단과 치료 [Speaker] In-Cheol Kim/Keimyung Univ., Korea
13:50-14:05	Discussion

Cardio-cerebrovascular Disease Prevention

KSC

Cardio-cerebrovascular Disease Prevention

High-Risk Pregnancy and Lifelong Cardiovascular Health: From Early Risk to Prevention

Apr. 18 (Sat.) 12:35-14:05, 205

Chairpersons : Sang Hyun Ihm , Seonghoon Choi

Panel : Eui-Soon Kim , Jung Sun Kim , Jin Bae Lee , Hokyou Lee , Hyun Joung Lim , Kina Jeon

Learning Objective: 1. To understand the epidemiological association between high-risk pregnancy and the long-term risk of cardiovascular disease in both mothers and their offspring.
2. To understand the biological significance of placental pathology findings as indicators of future cardiovascular risk.
3. To recognize the need for and feasibility of establishing national- and hospital-level registries for the systematic follow-up and management of patients with high-risk pregnancies.

12:35-12:55	The Epidemiology of High-Risk Pregnancy and Future Cardiovascular Risk [Speaker] Hyeon Chang Kim/Yonsei Univ., Korea
12:55-13:15	Placental Pathology: Clues to Future Cardiovascular Disease [Speaker] Eun Na Kim/Seoul National Univ., Korea
13:15-13:35	Building a High-Risk Pregnancy Registry: Are We Ready for Lifelong Prevention? [Speaker] Hyun-sun Ko/Catholic Univ., Korea
13:35-14:05	Discussion

14:25-15:55

KSoLA 3

KSoLA

KSoLA 3

Dyslipidemia management in special population?

Apr. 18 (Sat.) 14:25-15:55, 102

Chairpersons : Ki Hoon Han , Sung Rae Kim

Panel : Seon Mee Kang , Hack-Lyoung Kim , Ye Seul Yang , Jin Kyung Oh

Learning Objective: 1. 고령 및 허약 노인에서 스타틴의 유익함과 위험성, 용량 조절, 중단 또는 감량 시점을 개별화해 결정하는 원칙을 이해한다.
2. 임신 및 수유 중인 여성에서 이상지질혈증 평가, 금기약과 대체요법, 생활요법 중심 관리 전략을 체계적으로 정리한다.
3. 암 환자에서 스타틴의 심혈관 보호효과와 약물상호작용, 수술 및 항암치료 전후 지속 또는 중단 기준을 이해하고 실제 사례에 적용한다.

14:25-14:45	Intensity matters: LDL lowering in advanced age and frailty [Speaker] Eu Jeong Ku/Seoul National Univ., Korea
14:45-15:05	Practical lipid care in pregnancy [Speaker] In-Jeong Cho/Ewha Womans Univ., Korea
15:05-15:25	Oncology meets lipids: statins in cancer care [Speaker] Mi-Hyang Jung/Catholic Univ., Korea
15:25-15:45	Discussion

KPHS 3

KPHS

KPHS 3

Genetic Insights into Pediatric Heart Disease

Apr. 18 (Sat.) 14:25-15:55, 104

Chairpersons : June Huh , Jae Young Lee

Panel : Jung Eun Kwon , Ji Eun Ban , Ja Kyoung Yoon , Min-Jung Cho , In Su Choi

Learning Objective: This session will review the indications for genetic testing in pediatric heart disease, the interpretation of test results, and their clinical applications.

14:25-14:40	Genetics in Congenital Heart Disease: When, Whom, and How to Evaluate [Speaker] Jung Min Ko/Seoul National Univ., Korea
14:40-14:55	Genetic Causes of Cardiomyopathy: Early Detection and Clinical Implications [Speaker] Kee Soo Ha/Korea Univ., Korea
14:55-15:10	Inherited Arrhythmia Syndromes in Children: Variant Interpretation to Clinical Decision-Making [Speaker] Mi-Kyoung Song/Seoul National Univ., Korea
15:10-15:25	Inherited Aortic Aneurysmal Disease: Genetic Mechanisms and Clinical Implications [Speaker] Hee Joung Choi/Keimyung Univ., Korea
15:25-15:40	VUS(Variant of Unknown Significance) in Pediatric Heart Disease: Practical Approaches to Interpretation and Follow-Up [Speaker] Ja-Hyun Jang/Sungkyunkwan Univ., Korea
15:40-15:55	Discussion

KHRS4-VT

KHRS

KHRS4-VT

Ventricular Tachycardia

Apr. 18 (Sat.) 14:25-15:55, 105

Chairpersons : Tae-Joon Cha , Gibyoung Nam

Panel : Do Young Kim , Jin-Bae Kim , Soyoon Park , Hyung Wook Park , Chang-ok Seo

Learning Objective: 1. 다양한 심실 빈맥을 mapping 하고 ablation 할 수 있는 능력을 습득한다
2. 심실 빈맥의 mapping이 어려울 때 적용할 수 있는 팁을 습득한다
3. 약물적 치료와 시술적 치료의 장단점에 대해 이해한다

14:25-14:40	My tips for Mapping Ventricular Tachycardia Originating from Left Ventricle or Epicardium [Speaker] Jaemin Shim/Korea Univ., Korea
14:40-14:55	Mapping and Ablation of Outflow Tract Ventricular Tachycardias not Easily Induced in EP Lab [Speaker] Young Choi/Catholic Univ., Korea
14:55-15:10	Maintaining adequate potassium levels in patients at high risk for ventricular arrhythmias [Speaker] Hee Jeong Lee/Keimyung Univ., Korea
15:10-15:25	Mapping and Ablation of Hemodynamically Intolerable Ventricular Tachycardias [Speaker] Juwon Kim/Sungkyunkwan Univ., Korea
15:25-15:40	Finding P1 Potentials in ILVT Patients [Speaker] Il-Young Oh/Seoul National Univ., Korea
15:40-15:55	Discussion

KSHF 3

KSHF

KSHF 3

Imaging in Heart Failure Diagnosis and Treatment [Cross-Specialty]

Apr. 18 (Sat.) 14:25-15:55, 203

Chairpersons : Eung Ju Kim , Sung Min Ko

Panel : Bong Joon Kim , Hyung Yoon Kim , Jooyeon Lee , Eui-Young Choi

Learning Objective: 1. 심부전 환자에서 Echo, Cardiac MR, CT는 상호보완적인 역할을 하면서 진단과 치료 방향 결정, 예후 평가에 중요한 역할을 하고 있어, 이 세션에서는 HF Imaging이라는 주제하에 심부전환자에서 영상진단의 적절한 활용법을 배울 수 있습니다.
2. 심부전 환자의 실제 임상환경에서 흔히 접하는 상황에 대해서 최근 업데이트된 내용을 공부하여 임상 활용할 수 있습니다.

14:25-14:40	Distinguishing Ischemic from Non-Ischemic Dilated Cardiomyopathy: A Stepwise and Efficient Diagnostic Approach [Speaker] Junho Hyun/Ulsan Univ., Korea
14:40-14:55	Cardiac MR Imaging in Myocarditis and its' Mimickers [Speaker] Young Jin Kim/Yonsei Univ., Korea
14:55-15:10	Diagnosis of HF with Preserved EF and Estimation of LA Pressure: What's New? [Speaker] Ju-Hee Lee/Chungbuk National Univ., Korea
15:10-15:25	Low Contrast or Noncontrast Imaging in HF with Renal Dysfunction [Speaker] Jong Eun Lee/Ulsan Univ., Korea
15:25-15:40	Treatment of Ventricular Functional MR Based on Mechanisms and Imaging [Speaker] Chi Young Shim/Yonsei Univ., Korea
15:40-15:55	Discussion

KSIC 4

KSIC

KSIC 4

심장내과의사와 전공의를 위한 대퇴슬와동맥질환의 기본

Apr. 18 (Sat.) 14:25-15:55, 300B

Chairpersons : Donghoon Choi , Seung Hyuk Choi

Panel : Su Hong Kim , Pil-Ki Min , Jon Suh , Chang-Hwan Yoon

Learning Objective: 흔하지만 심장내과의사가 잘 모르는 말초동맥 질환 및 심부정맥 혈전증에 대해서 최고의 전문가들이 쉽게 알려드립니다. 본 세션을 통해 실제 진료에서 이러한 환자들을 보다 자신 있게 평가하고 관리하는 데 도움이 될 것입니다.
말초동맥질환의 진단, 대퇴슬와동맥의 중재시술 (혈관내치료)의 기본, 약물치료, 드물지만 중요한 대퇴슬와동맥관련질환과 흔한 심부정맥 혈전증에 대해서 알고 싶으시면 부담없이 오세요.

14:25-14:40	CAD에서 PAD의 Screening이 왜 중요하며, 어떻게 진단해야 하는가? [Speaker] Sanghoon Shin/Ewha Womans Univ., Korea
14:40-14:55	초보자는 대퇴슬와동맥의 중재시술(혈관내치료)를 어떻게 준비하고 시작해야 하는가? [Speaker] Ho Youn Won/Chung-Ang Univ., Korea
14:55-15:10	Claudication과 CLTI환자는 약물치료와 보조적 치료(재활 등)는 어떻게 해야 하는가? [Speaker] Ji Yong Jang/National Health Insurance Service Ilsan Hospital, Korea
15:10-15:25	드물지만 놓치면 안 되는 Nonatherosclerotic Popliteal Artery Diseases는 어떤 것이 있는가? [Speaker] Young Jin Youn/Yonsei Wonju Univ., Korea
15:25-15:40	흔히 만나게 되는 심부정맥 혈전증은 재개통술과 약물치료 어떻게 해야 하는가? [Speaker] Ji Bak Kim/Hanil General Hospital, Korea
15:40-15:55	Discussion

Education Workshop 4 - Echocardiography

KSC

Education Workshop 4 - Echocardiography

Echocardiograph Update 2026

Apr. 18 (Sat.) 14:25-15:55, 300C

Chairpersons : Goo-Yeong Cho , Jae-Hyeong Park

Panel : So Ree Kim , Hyung Seop Kim , Jang Won Sohn , Sun Hwa Lee

Learning Objective: 1. To understand the key echocardiographic features for the diagnosis and differentiation of ATTR cardiomyopathy and hypertrophic cardiomyopathy, and to recognize their clinical role and value.
2. To be familiar with the key parameters and principles for assessing diastolic function based on the latest guidelines, and to apply them in various clinical settings.
3. To understand the major updates and key messages of the latest valvular heart disease guidelines, and to incorporate echocardiography-based severity assessment into clinical decision-making.

14:25-14:40	Mastering Diastolic Function: A Practical Update Based on the Latest Guidelines [Speaker] Sung-Hee Shin/Inha Univ., Korea
14:40-14:55	Solving the Puzzle: Navigating Discordant Parameters in Grading Valvular Heart Disease [Speaker] Dae-Hee Kim/Ulsan Univ., Korea
14:55-15:10	Unmasking Hypertrophy: The Role of Echocardiography in Hypertrophic Cardiomyopathy [Speaker] Jihoon Kim/Sungkyunkwan Univ., Korea
15:10-15:25	Echocardiography in Transthyretin Cardiac Amyloidosis: From Early Detection to Phenotyping [Speaker] Inki Moon/Soonchunhyang Univ., Korea
15:25-15:40	Management and Monitoring of ATTR-CM and HCM in the Era of New Therapies [Speaker] Hyun-Jung Lee/Seoul National Univ., Korea
15:40-15:55	Discussion

08:00-08:45

ENG Valvular Diseases and Structural Interventions 4

ACC

ENG Valvular Diseases and Structural Interventions 4

Valvular Disease Controversies: Lifetime Management and Therapy Choices

Apr. 18 (Sat.) 08:00-08:45, 202

Chairpersons : Kiyuk Chang , Kyoo Rok Han

Panel : Ramesh Babu Daggubati , Jae Yeong Cho , Seong-Mi Park

08:00-08:10	Lifetime Management in the Selection of Therapies For Patients [Speaker] Jin Sun Park/Ajou Univ., Korea
08:10-08:20	Concomitant Valvular and Coronary Artery Diseases [Speaker] Ramesh Babu Daggubati/West Virginia University, USA
08:20-08:30	Antithrombotic or Anticoagulation Therapies [Speaker] Sanjay Tyagi/Apollo Hospital Group, India
08:30-08:45	Panel Discussion With Audience Question and Answer

ENG Cardiovascular Disease Prevention 3

ACC

ENG Cardiovascular Disease Prevention 3

Obesity Management in Asia: Medical, Surgical, and Emerging Therapies

Apr. 18 (Sat.) 08:00-08:45, 205

Chairpersons : Ade Meidian Ambari , Sang Hyun Ihm

Panel : Kina Jeon , Minjae Yoon , Jong-Chan Youn

08:00-08:10	Review of the 2025 ACC Expert Consensus Statement on Medical Weight Management [Speaker] Eugene Yang/University of Washington School of Medicine, USA
08:10-08:15	Discussion
08:15-08:25	The Evolving Landscape of Obesity Management: Current and Emerging Therapies [Speaker] Yun Kyung Cho/Ulsan Univ., Korea
08:25-08:30	Discussion
08:30-08:40	The Landscape of Metabolic Surgery in Asia [Speaker] Han Hong Lee/Catholic Univ., Korea
08:40-08:45	Discussion

ENG Cardiac Arrhythmias 2

ACC

ENG Cardiac Arrhythmias 2

Advances in Stroke Prevention For Atrial Fibrillation: Evidence and Innovation

Apr. 18 (Sat.) 08:00-08:45, 300A

Chairperson : Eue-Keun Choi

Panel : Andrea M. Russo , Jum Seok Ko , Hyo-Jeong Ahn

08:00-08:10	New Evidence of Stroke Prevention in Patients With AFib and CAD [Speaker] Hee Tae Yu/Yonsei Univ., Korea
08:10-08:15	Panel Discussion With Audience Question and Answer
08:15-08:25	What's New with Oral Anticoagulants: Factor XI/X1a Inhibitors [Speaker] Andrea M. Russo/Cooper Medical School of Rowan University, USA
08:25-08:30	Panel Discussion With Audience Question and Answer
08:30-08:40	Recent Update on Anticoagulation After Successful AFib Ablation [Speaker] Boyoung Joung/Yonsei Univ., Korea
08:40-08:45	Panel Discussion With Audience Question and Answer

08:55-09:40

ENG Plenary 3 (Top Clinical Trials）

ACC

ENG Plenary 3 (Top Clinical Trials）

Apr. 18 (Sat.) 08:55-09:40, 300A

Chairpersons : Bonnie Ky , Myeong Ki Hong

Panel : Ki Hong Choi , Jiesuck Park , So-Ryoung Lee

08:55-08:56	Introduction
08:56-09:01	Ultrasound-facilitated Catheter-directed Thrombolysis Vs Anticoagulation Alone For Acute Intermediate-high-risk Pulmonary Embolism: Primary Results Of The HI-PEITHO Randomized Clinical Trial [Speaker] Ramesh Babu Daggubati/West Virginia University, USA
09:01-09:07	Discussion
09:07-09:12	Outcomes In Patients With Atrial Fibrillation Randomized To Receive Left Atrial Appendage Closure Or Oral Anticoagulation: Primary Results Of The CHAMPION-AF Clinical Trial [Speaker] Andrea M. Russo/Cooper Medical School of Rowan University, USA
09:12-09:18	Discussion
09:18-09:23	Controlled Trial Of High-Risk Coronary Intervention With Percutaneous Left Ventricular Unloading (CHIP-BCIS3) [Speaker] Kwan Seung Lee/Mayo Clinic Arizona, USA
09:23-09:29	Discussion
09:29-09:34	Intensive Low-density Lipoprotein Cholesterol Targeting In Patients With Atherosclerotic Cardiovascular Disease [Speaker] Byeong-Keuk Kim/Yonsei Univ., Korea
09:34-09:40	Panel Discussion With Audience Question and Answer

09:50-10:35

ENG Research Workshop: Part 1

ACC

ENG Research Workshop: Part 1

Apr. 18 (Sat.) 09:50-10:35, 202

Chairpersons : Bonnie Ky , Harlan M. Krumholz

Panel : Bon-Kwon Koo , Duk-Woo Park , Roxana Mehran , Jae-Sun Uhm

09:50-09:53	Introduction [Speaker] Bonnie Ky/University of Pennsylvania School of Medicine, USA
09:53-10:01	Demystifying the Peer Review Process [Speaker] Duk-Woo Park/Ulsan Univ., Korea
10:01-10:16	Breakout Activity: Small Group Discussion
10:16-10:24	Manuscript Preparation and Authorship [Speaker] Harlan M. Krumholz/Yale School of Medicine, USA
10:24-10:39	Breakout Activity: Writing Exercise
10:39-10:44	Break

ENG Cardiac Arrhythmias 3 (Joint Society Session with Korean Heart Rhythm Society)

ACC

ENG Cardiac Arrhythmias 3 (Joint Society Session with Korean Heart Rhythm Society)

Ventricular Tachycardia in Cardiomyopathy: Mapping, Genetics, and Imaging

Apr. 18 (Sat.) 09:50-10:35, 205

Chairpersons : Andrea M. Russo , Hui Nam Pak

Panel : Sang Weon Park , Min Soo Cho , Jin-Kyu Park

09:50-10:05	VT Localization: QRS Discrepant From VT Origin [Speaker] Ju Youn Kim/Sungkyunkwan Univ., Korea
10:05-10:12	Panel Discussion With Audience Question and Answer
10:12-10:27	Recent Update on VT Mapping and Ablation in ARVC [Speaker] Kyoung-Min Park/Sungkyunkwan Univ., Korea
10:27-10:35	Panel Discussion With Audience Question and Answer

ENG Cardiovascular Disease Prevention 4

ACC

ENG Cardiovascular Disease Prevention 4

Global Perspectives on Blood Pressure Guidelines: ACC/AHA, KSH, and JSH

Apr. 18 (Sat.) 09:50-10:35, 300A

Chairpersons : Kwang-il Kim , Eugene Yang

Panel : Ade Meidian Ambari , Dae Young Cheon , Eui-Soon Kim

09:50-10:00	Overview of AHA/ACC Multi-Society Blood Pressure Guideline [Speaker] Eugene Yang/University of Washington School of Medicine, USA
10:00-10:10	Korean Society of Hypertension (KSH) BP Guideline Review [Speaker] Sung Ha Park/Yonsei Univ., Korea
10:10-10:20	Japanese Society of Hypertension (JSH) Guidelines For the Management of Elevated Blood Pressure and Hypertension [Speaker] Junya Ako/Kitasato University, Japan
10:20-10:35	Discussion

10:45-11:30

ENG Research Workshop: Part 2

ACC

ENG Research Workshop: Part 2

Apr. 18 (Sat.) 10:45-11:30, 202

Chairpersons : Bonnie Ky , Harlan M. Krumholz

Panel : Bon-Kwon Koo , Duk-Woo Park , Roxana Mehran , Jae-Sun Uhm

10:44-10:52	Selecting the Right Journal and Submission Strategies [Speaker] Harlan M. Krumholz/Yale School of Medicine, USA
10:52-11:00	Responding to Reviewer Comments [Speaker] Duk-Woo Park/Ulsan Univ., Korea
11:00-11:15	Breakout Activity: Peer Feedback Practice
11:15-11:30	Panel Discussion With Audience Question and Answer

ENG Cardiac Arrhythmias 4 (Joint Society Session with Korean Heart Rhythm Society)

ACC

ENG Cardiac Arrhythmias 4 (Joint Society Session with Korean Heart Rhythm Society)

Device Therapies in Heart Failure: Innovations and Clinical Impact

Apr. 18 (Sat.) 10:45-11:30, 205

Chairpersons : Seil Oh , Seok-Min Kang

Panel : Jaewon Oh , Sung-Hee Shin , Min Kim

10:45-10:55	Recent Advancement on Prevention of Sudden Cardiac Death in HF Patients [Speaker] Lae Young Jung/Jeonbuk National Univ., Korea
10:55-11:00	Panel Discussion With Audience Question and Answer
11:00-11:10	New Insight on Pacing-Induced Cardiomyopathy [Speaker] So-Ryoung Lee/Seoul National Univ., Korea
11:10-11:15	Panel Discussion With Audience Question and Answer
11:15-11:25	CRT vs Conduction System Pacing For HF With Reduced or Mildly Reduced EF [Speaker] Pugazhendhi Vijayaraman/Geisinger Heart Institute, USA
11:25-11:30	Panel Discussion With Audience Question and Answer

ENG Coronary Interventions and Ischemic Heart Diseases 4

ACC

ENG Coronary Interventions and Ischemic Heart Diseases 4

Personalizing Antiplatelet Therapy: Risk, Genetics, and Regional Insights

Apr. 18 (Sat.) 10:45-11:30, 300A

Chairpersons : Kyung Woo Park , Kwan Seung Lee

Panel : Rodney Jimenez , Sung Eun Kim , Ramesh Babu Daggubati

10:45-10:55	Should All Patients Undergo Standard DAPT De-escalation Following Acute Myocardial Infarction? [Speaker] Chan Joon Kim/Catholic Univ., Korea
10:55-11:00	Panel Discussion With Audience Question and Answer
11:00-11:10	Bleeding / Thrombotic Risk Profiles of East Asian Patients [Speaker] Jeehoon Kang/Seoul National Univ., Korea
11:10-11:15	Panel Discussion With Audience Question and Answer
11:15-11:25	In the Era of De-Escalation Is There a Role for CYP2C19 Genetic Testing? [Speaker] Roxana Mehran/Icahn School of Medicine at Mount Sinai, USA
11:25-11:30	Panel Discussion With Audience Question and Answer

12:35-13:20

ENG Multimodal Imaging 3

ACC

ENG Multimodal Imaging 3

Top Three Innovations or Hot Topics in Multimodal Imaging

Apr. 18 (Sat.) 12:35-13:20, 202

Chairpersons : Cynthia Taub , Sang-Chol Lee

Panel : Sung Min Ko , In-Cheol Kim , Jae K. Oh

12:35-12:45	Top Three Innovations or Hot Topics in CMR [Speaker] Eui-Young Choi/Yonsei Univ., Korea
12:45-12:55	Top Three Innovations or Hot Topics in Echocardiography [Speaker] Cynthia Taub/SUNY Upstate Medical University, USA
12:55-13:05	Top Three Innovations or Hot Topics in CT [Speaker] Tiffany Chen/University of Washington, USA
13:05-13:20	Panel Discussion With Audience Question and Answer

ENG Special Topics 6 (Digital Health in Cardiology: AI, Wearables, and Imaging)

ACC

ENG Special Topics 6 (Digital Health in Cardiology: AI, Wearables, and Imaging)

Apr. 18 (Sat.) 12:35-13:20, 300A

Chairpersons : Young Hak Kim , Kwan Seung Lee

Panel : Harlan M. Krumholz , Kin-Lam Tsui , Soonil Kwon

12:35-12:45	AI in Wearables For Population Health [Speaker] Joon-Myoung Kwon/Incheon Sejong Hospital, Korea
12:45-12:55	AI in Echo Imaging [Speaker] Federico M. Asch/MedStar Health and Georgetown University, USA
12:55-13:05	AI in CT Plaque Analysis [Speaker] Bon-Kwon Koo/Seoul National Univ., Korea
13:05-13:20	Panel Discussion With Audience Question and Answer

13:30-14:15

ENG Multimodal Imaging 4

ACC

ENG Multimodal Imaging 4

From Leads to Leaflets: Multimodality Imaging in the Diagnosis of Endocarditis

Apr. 18 (Sat.) 13:30-14:15, 202

Chairpersons : William Kong , Hae Ok Jung

Panel : Smonporn Boonyaratavej Songmuang , Dae-Hee Kim

13:30-13:40	CIED-related Infective Endocarditis [Speaker] Cynthia Taub/SUNY Upstate Medical University, USA
13:40-13:50	Prosthetic Valve Endocarditis [Speaker] William Kong/The National University Heart Centre Singapore, Singapore
13:50-14:00	Non-bacteria Thrombotic Endocarditis [Speaker] Hyun-Jung Lee/Seoul National Univ., Korea
14:00-14:15	Panel Discussion With Audience Question and Answer

ENG Heart Failure and Cardiomyopathies 4

ACC

ENG Heart Failure and Cardiomyopathies 4

Acute Heart Failure: Managing Cardiorenal Syndrome and Shock

Apr. 18 (Sat.) 13:30-14:15, 300A

Chairpersons : Seok-Min Kang , Mayanna Lund

Panel : Ji-Hun Jang , Min-Seok Kim , Aekarach Ariyachaipanich

13:30-13:40	Defining and Overcoming Diuretic Resistance [Speaker] Aekarach Ariyachaipanich/Chulalongkorn University, Thailand
13:40-13:45	Panel Discussion With Audience Question and Answer
13:45-13:55	Cardiorenal Syndrome: Pathophysiology to Intervention [Speaker] Jennifer A. Cowger/Michigan State University, USA
13:55-14:00	Panel Discussion With Audience Question and Answer
14:00-14:10	Cardiogenic Shock: Fundamentals of Managing Shock Due to Acute Myocardial Infarction vs. Chronic Heart Failure [Speaker] Jeong Hoon Yang/Sungkyunkwan Univ., Korea
14:10-14:15	Panel Discussion With Audience Question and Answer

14:25-15:10

ENG Plenary 4 (STEMI Care Delivery: Global Disparities and Solutions)

ACC

ENG Plenary 4 (STEMI Care Delivery: Global Disparities and Solutions)

Apr. 18 (Sat.) 14:25-15:10, 300A

Chairpersons : Hyo-Soo Kim , Kwan Seung Lee

Panel : Jin Man Cho , Dong Oh Kang , Hyung Joon Joo

14:25-14:35	High Income Country [Speaker] Jang-Whan Bae/Good Samsun Hospital, Korea
14:35-14:45	Lower Middle Income Country
14:45-14:55	Lower Middle Income Country [Speaker] Sanjay Tyagi/Apollo Hospital Group, India
14:55-15:10	Panel Discussion With Audience Question and Answer

15:20-16:05

ENG Convocation and Closing Ceremony

ACC

ENG Convocation and Closing Ceremony

Apr. 18 (Sat.) 15:20-16:05, 300A

Presenter : Kwan Seung Lee , Seok-Min Kang , Roxana Mehran

Detailed Program

Detailed Program

ENG Opening Ceremony

Basic Research 1

Myocardial Infarction 1

ENG Hypertension

KSHF 1

Cardiometabolic Syndrome 1

Interesting ECG

ENG Basic Research 2

Insurance Issues

Pulmonary Hypertension

Cardiac Pathology

Cardiometabolic Syndrome 2

KHRS1-AF

Scientific Session [Chong Kun Dang]

Scientific Session [Hanmi]

Scientific Session [Novartis]

Scientific Session [Amgen]

Scientific Session [Boryung]

Scientific Session [Samjin]

Scientific Session [Organon]

ENG Suh, Soon Kyu Memorial Lecture

Adult Congenital Heart Disease 1

Myocardial Infarction 2

Women Heart Disease

Cardiovascular Imaging

KSIC 1

KHRS2-SCD

Rare Genetic CVD 1

Adult Congenital Heart Disease 2

ENG Epidemiology

KSE 1

ENG Cardio-Oncology

Healthcare Policy

KSoLA 1

Rare Genetic CVD 2

ENG Multimodal Imaging 1 (Joint Session with Korean Society of Echocardiography)

ENG Plenary 1 (INOCA/ANOCA: An Emerging Global Issue)

ENG Special Topics 1 (Pediatric Cardiology: Prevention, Kawasaki Disease, and Lifelong Risk)

ENG Multimodal Imaging 2 (Joint Session with Korean Society of Echocardiography)

ENG Cardiac Arrhythmias 1

ENG Special Topics 2 (Women’s Heart Disease: Hormones, Rhythm, and Risk)

ENG Heart Failure and Cardiomyopathies 1 (Joint Society Session with Korean Society of Heart Failure)

ENG Valvular Diseases and Structural Interventions 1

ENG Special Topics 3 (Genomics and Genetics in Cardiovascular Disease: From Cardiomyopathy to Dyslipidemia）

ENG Heart Failure and Cardiomyopathies 2 (Joint Society Session with Korean Society of Heart Failure)

ENG Valvular Diseases and Structural Interventions 2

ENG Coronary Interventions and Ischemic Heart Diseases 1

ENG Cardiovascular Disease Prevention 1 (Joint Session with Korean Society of Lipid and Atherosclerosis)

ENG Heart Failure and Cardiomyopathies 3

Special Topics 4（Cardio-Oncology: Bridging Cancer and Cardiovascular Care）

ENG Cardiovascular Disease Prevention 2 (Joint Session with Korean Society of Lipid and Atherosclerosis)

ENG Valvular Diseases and Structural Interventions 3

ENG Coronary Interventions and Ischemic Heart Diseases 2 (Joint Session with Korean Society of Interventional Cardiology)

ENG Plenary 2 (Leveraging AI in EMR and Beyond)

ENG Coronary Interventions and Ischemic Heart Diseases 3 (Joint Session with Korean Society of Interventional Cardiology)

ENG FIT Jeopardy: The Classic Game Show With a FIT Twist!

Cardiogenic Shock

Cardiac Surgery

KSE 2

ENG Vascular Research 1

KSIC 2

Education Workshop 1 - Arrhythmia

Cardiovascular Genome and Precision Medicine

ENG KPHS 1

ENG KSE 3

KSHF 2

Smart Health

Education Workshop 2 - Hypertension

Scientific Session [Daiichi Sankyo/Daewoong]

Scientific Session [JW Pharm]

Scientific Session [Viatris]

Scientific Session [Sky Labs]

ENG Special Topics 5 (Women in Cardiology: Pathways to Success and Leadership)

Scientific Session [Yuhan]

Scientific Session [Celltrion Pharm/Daewon]

KSoLA 2

ENG KPHS 2

KHRS3-CIED